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Ashish Suresh Yeri, Ph.D. 
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DNA-based biosensors for detection of genetic mutations and infectious diseases have attracted a 
lot of attention recently owing to the large amount of genetic information available and the high 
specificity of these sensors due to the uniqueness of DNA sequences.  
In the first part of my work, the viscoelastic properties of single-strand DNA are made 
use of to rapidly screen for disease causing mutations. Single strand DNA (ssDNA) films have 
viscoelastic properties which are dependent on their 3-D conformation in solution which in turn 
is dependent on their base sequence. The mutation of the p53 gene which is responsible for 
almost half of all cancers was chosen as our case study.   The appreciable differences in the 
viscoelastic properties between the p53 wild type ssDNA film and the p53 mutant R type ssDNA 
film were evaluated using a quartz crystal resonator showing that this method holds much 
promise to be used as a rapid DNA mutation screening technique.  
In the second part of my work, we have made use of novel isothermal DNA amplification 
techniques to specifically amplify the target DNA which is then detected on lateral flow strips in 
a low cost manner. Escherichia coli and Klebsiella pneumoniae are responsible for a large 
number of infections including Urinary Tract Infection (UTI) and life threatening conditions 
such as neonatal meningitis and neonatal sepsis. A rapid and sensitive detection scheme has been 
developed for these bacteria by amplification of the DNA with Loop mediated isothermal 
amplification technique (LAMP) and its subsequent detection on lateral flow strips. Patient urine 
samples were screened for the presence of these two organisms and the LAMP-lateral flow 
detection scheme is comparable to the bacterial culture methods which is the current gold 
 v 
standard. Furthermore, multiplexing the amplification and detection has been demonstrated 
successfully which shows great potential to be employed as a reliable point-of-care diagnostic 
tool in the clinical setting. 
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1.0  INTRODUCTION 
Sensors which incorporate biomolecules such as cells, proteins/antibodies or DNA to sense the 
target analyte which may be another biomolecule, trace chemicals, etc. are termed biosensors. 
Typically these biomolecules are integrated to the transducer surface via physical adsorption or 
chemisorption. The interaction or binding between the target analyte and the biomolecule is 
sensed by the sensor which is converted into an analytical signal to be amplified or processed. 
The greatest advantage offered by biosensors is their sensitivity and selectivity to the target 
analyte from a complex media. The selectivity is entirely due to the choice of the right 
biomolecule (the sensing element) which should have the highest affinity for the target analyte 
whereas the sensitivity is affected by the orientation of the biomolecules after immobilization 
onto the transducer surface and also the efficiency with which the transducer detects this 
interaction 1. The former aspect is discussed in detail in chapter 3.2.    
Biosensors which are based on the affinity between the target analyte to the biomolecule 
are termed affinity based biosensors where the target analyte binds irreversibly to the 
biomolecule as in the case of sensors which are based on antigen-antibody or hapten-antibody 
interaction. In catalytic biosensors, the concentration of the target analyte is related to the 
progress of a chemical reaction which is bio-catalyzed2. The glucose biosensor which accounts 
for 85% of the market 3for biosensors is based on the enzyme glucose oxidase which oxidizes β-
D Glucose to gluconic acid and hydrogen peroxide. The amount of glucose is sensed by 
measuring the amount of oxygen consumed, or by measuring the amount of hydrogen-peroxide 
formed or by measuring the electron flow resulting from the oxidation reaction4.  
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The function of the transducer is to sense the physico-chemical change induced after the 
target binds to the biomolecule and to convert it into a measurable quantity. The commonly used 
transducers are optical transducers, thermometric transducers, piezoelectric transducers and 
electrochemical. Biosensors find uses in a plethora of fields such as in the medical field in the 
detection of pathogens, tumor markers, toxic metabolites, glucose monitoring, and routine 
analytical measurement of patient samples in point-of-care diagnostics. In the food industry, 
biosensors are used for the detection of bacteria in decaying food and to assess process quality. 
They are used in drug discovery and in the evaluation of biological activity of new compounds. 
Recently, they have been used in the detection of chemical weapons, drugs and narcotics.  
 
DNA-based Biosensors 
 
Biosensors which incorporate DNA molecules as the sensing element are termed as DNA 
biosensors.  With the enormous success of the human genome project, a large amount of genetic 
data has been made available rapidly which holds great promise for detection of genetic diseases 
early on which could possibly prevent their occurrence by administering the right treatment. The 
uniqueness of the DNA sequences whether one is looking to detect point mutations in cancer 
research and therapy or for the detection of one among many bacterial/viral strains makes the use 
of DNA biosensors as specific as there can be at the moment. Furthermore, in many cases the 
isolation of the pathogenic micro-organisms is not necessary and the detection can be carried out 
with the contents from the dead cells. This provides a big advantage over cell culture methods 
which are tedious and time consuming. Therefore there is a need for design of simple, rapid, 
affordable DNA based biosensors which not only would help in decentralizing diagnostic testing, 
but would also be useful to be deployed in third world countries where sensitive, rapid and cheap 
diagnostics would be invaluable.  
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Currently most of the DNA biosensors are based on nucleic acid (NA) hybridization. 
Single strand DNA (ssDNA) hydrogen bond to other ssDNA strands according to the Watson-
Crick pairing rules: Adenine with Thymine (forming two hydrogen bonds) and Cytosil with 
Guanine (forming three hydrogen bonds) which is termed as DNA-DNA hybridization. Typically 
a short single strand DNA (ssDNA) molecule (10-30 mers) is immobilized onto the surface of 
the transducing element and is allowed to bind to its complementary strand in solution. The most 
common transducing techniques employed to detect the hybridization are optical, 
electrochemical and piezoelectric and colorimetric.  
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1.1 OPTICAL TRANSDUCTION 
Optical transduction makes use of optic-fiber cables where the excitation light of a particular 
wavelength from the source passes through the optic-fiber cable by a series of total internal 
reflections due to the difference in the refractive indices of the core of the optic-fiber and the 
cladding. Excitation light of a particular wavelength is passed through the optic-fiber which 
excites the fluorescent labeled biomolecule and the light emitted by the label passes through the 
same optic-fiber cable which is separated and detected by an optical detector. Typically, the 
ssDNA probe is attached to the optic-fiber at the distal end, 5,6or on the outer surface of the core7-
9. The hybridization of the complementary sequence to an immobilized ssDNA probe can be 
detected in one of two ways. After hybridization, double strand DNA (dsDNA) specific 
fluorescent dyes such as Ethidium bromide8, PicoGreen6 are allowed to bind to the dsDNA 
complex and the fluorescence can be detected by an optic fiber or fluorescently labeled 
complementary strands are allowed to bind to the immobilized ssDNA on the optic-fiber surface.  
Short ssDNA probes (16-20 mer) were used to detect fluorescent labeled DNA targets on the 
surface of an optic fiber cable10. The detection of hybridization of 16 mer fluorescent labeled 
ssDNA strands in solution to ssDNA probe immobilized on the fiber-optic surface was 
demonstrated by Abel et al9. Here, the fluorescence intensity was monitored in real time and the 
biosensor could be regenerated over many cycles by chemical and thermal denaturation. Fiber-
optic bundles, each immobilized with a different ssDNA probe on its distal end were used to 
detect multiple fluorescently labeled ssDNA strands rapidly (< 10 minutes) upto a concentration 
of 10nM in solution11. Other novel systems have been explored with optical transduction such as 
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bead based arrays where selective chemical etching of the cladding produces microspheres 
assembled in micro-wells onto which ssDNA probes are attached12,13.   
1.2 ELECTROCHEMICAL TRANSDUCTION 
In electrochemical transduction, detection of hybridization is accomplished by electro-active 
hybridization indicators which interact differently with ssDNA and dsDNA. A variety of 
molecules can be used as hybridization indicators which bind to dsDNA reversibly through 
electrostatic binding or intercalation (fitting themselves between the base pairs of dsDNA 
molecules). Transition metal complexes such as Pt, Ru, Co, and Fe complexes and heterocyclic 
dyes such as Ethidium Bromide, anthracyclines, phenothiazines, and acridine derivatives, bind 
reversibly through intercalation. Transition metal complexes of Cobalt (Co(bpy)33+ and 
Co(phen)33+14, organic dyes such as methylene blue, enzyme labeled DNA probes15-17 have 
been successfully implemented to detect DNA hybridization reactions electrochemically. Other 
electrochemical techniques include labeling with metal nanoparticles, and use of carbon 
nanotubes for detection of hybridization18.  
Label free electrochemical techniques although not as sensitive as labeled techniques 
eliminate the need for the label which could simplify the assay. Typically, the oxidation of 
guanine is monitored during hybridization by cyclic voltammetry19,20, square wave 
voltammetry21, adsorption stripping potentiometry22, differential pulse voltammetry23, etc. 
Label free techniques cause irreversible damage to the immobilized DNA and so are generally 
not preferred over labeled techniques.  
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1.3 PIEZOELECTRIC TRANSDUCTION 
Piezoelectric biosensors utilize surface acoustic wave based sensors such as the quartz 
crystal microbalance (QCM) where the quartz crystal resonates at a high frequency. Piezoelectric 
materials develop an electric potential when mechanical stresses are applied onto it and 
conversely, when an oscillating electric potential is applied, it vibrates at its resonant frequency. 
The resonant frequency of the quartz crystal reduces linearly according to the Sauerbrey equation 
(valid for rigid, thin films only)24 when any mass is adsorbed onto the surface of the quartz 
crystal and accurate measurements of the frequency can give mass sensitivities which are in the 
ng/cm2 range.  QCMs are highly sensitive mass sensors which can be used for mass detection in 
real time by monitoring the frequency decrease associated with the binding events as they 
happen. Typically, a ssDNA probe is immobilized onto the surface of the resonator by using 
thiol chemistry; thiolated ssDNA strands are allowed to bind to form a self assembled monolayer 
or by using biotin-avidin-biotinylated ssDNA sandwich structures to form a layer of ssDNA 
molecules on the resonator surface. The complementary strand is allowed to bind to this 
immobilized probe in solution and the frequency decrease associated with the hybridization is 
monitored over time. Examples of detection of DNA hybridization using piezoelectric sensors 
have been demonstrated for the detection of microalgae Alexandrium minutum which causes 
shell fish poisoning25, Salmonella typhimurium 26, E. coli genomic DNA27. The detection of 
point mutations by Su et al28 has been shown where the binding of protein MuTS (which binds to 
mismatched DNA pairs) can be discriminated for perfectly matched and imperfectly matched 
DNA hybrids. With energy dissipation monitoring for adsorbed films now available in most 
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commercially available QCMs, the mass of soft films, where the Sauerbrey equation fails, can be 
determined accurately29 making the piezoelectric sensing a robust technique to detect DNA 
hybridization. 
 
1.4 COLORIMETRIC ASSAYS 
Colorimetric techniques utilize reporter particles such as gold nanoparticles (GNPs) to 
detect the presence of the analyte visually without the need for expensive detectors. This makes 
this technique very promising to be used in point-of-care diagnostics, especially in developing 
countries. Colorimetric sensors already have been widely used in pregnancy test strips and in the 
detection of infectious diseases. DNA based colorimetric techniques rely on color change after 
the complementary strand hybridizes with GNP labeled ssDNA probes. The resulting polymeric 
network due to the hybridization reaction changes the color of the dispersed GNPs in solution 
from red to blue30,31.  
 
The goal of DNA-based biosensors is the detection of genetic diseases and detection of 
infectious diseases. The first part of my work deals with the detection of disease causing DNA 
mutations by making use of the viscoelastic properties of DNA strands and the second portion of 
my work is on rapid DNA-based diagnostics where isothermal DNA amplification techniques in 
conjunction with lateral flow assays are used to detect infectious microorganisms in a low cost 
manner.  
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2.0  MUTATION SCREENING BASED ON THE MECHANICAL PROPERTIES OF 
DNA MOLECULES  
2.1 INTRODUCTION 
The complete sequencing of the human genome has created a tremendous interest in large 
scale DNA characterization and sequencing32,33 . With the rapid increase in the number of 
mutations identified, detection of genetic variations in patients would bring about early diagnosis 
and even prevention of certain diseases like cancer. The current gold standard for identifying 
gene mutation is based on DNA sequencing technologies such as the capillary array 
electrophoresis. However, precisely sequencing a large number of samples is currently time-
consuming and expensive. Screening of gene mutations prior to precise mutation identification 
would significantly reduce the number of samples that need to be sequenced and, therefore, 
development of rapid, sensitive, and inexpensive technologies for DNA mutation screening is of 
great interest. Some of the current mutation screening technologies include allele specific 
oligonucleotides, protein truncation test, DNA microarray technology and electrophoretic 
mobility shift assays 32,34-39. Although these screening methods have all been explored to a 
reasonable degree of success40, they are limited by the length of the DNA that can be effectively 
screened per operation, which is apparently an important factor that determines the cost of 
mutation screening. Among them, the electrophoretic mobility shift assays, including single 
strand conformational polymorphism (SSCP) and heteroduplex analysis (HA), are able to screen 
longer DNA strands than other methods and have gain clinical popularity.  However, the 
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maximum length of the DNA that can be effectively screened by SSCP and HA is still limited to 
be less than 300 base pairs (bps) and the optimization of these electrophoretic mobility shift 
assays is highly empirical39.  
In this work, we demonstrate another effective approach for rapid gene mutation 
screening by making use of the mechanical properties of single-strand DNA (ssDNA).  It is 
based on the folding of ssDNA strands in aqueous solution and the immobilization of such 
strands to a quartz crystal resonator. We show that appreciable differences in the shear modulus 
can be detected between ssDNA films consisting of wild type and mutant type DNA strands of 
p53 gene, due to a single base mutation in a total of 545 bases. We choose to use the p53 gene 
and its mutant as an example to demonstrate the capability of this technology, because p53 gene 
has been used as examples for other mutation screening technologies32,34 and its importance has 
been extensively studied as its mutation leads to cancers such as breast cancer, bone cancer and 
bladder cancer41. 
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2.2 EXPERIMENTAL DETAILS 
2.2.1 DNA sample preparation  
The gene samples used were p53 wild type gene and p53 R type mutant, both containing 
1182 bps. A fragment of the genes containing 545 bases was amplified by PCR (Figure 1) . By 
modifying one primer with a biotin group at the 5’ end, biotin dsDNA strands were obtained. 
(Table 1). The amplification product was purified to remove the reaction buffer and the primers. 
The purified dsDNA was denatured at 95°C and cooled suddenly at -20°C to form ssDNA, with 
one strand containing biotin at the 5’ end and the other strand containing the complementary 
base sequence to the biotinylated strand. 100 μL of the purified ssDNA was diluted in 1.5 mL of 
phosphate buffered saline (PBS, pH 7.4) and this formed the sample that was introduced to the 
quartz crystal resonator. 
 
Table 1. PCR primers for amplification of p53 wild type and R type mutant genes: 
 
 Primer name 
 
Primer Sequence 
Forward primer  5’-biotin-TCATCTTCTGTCCCTTCCC-3’ 
 
Backward primer  5’-CAAACACGCACCTCAAAG-3’ 
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a.  p53 wild type gene sequence  
1    ATGGAGGAGC CGCAGTCAGA TCCTAGCGTC GAGCCCCCTC TGAGTCAGGA AACATTTTCA 
61   GACCTATGGA AACTACTTCC TGAAAACAAC GTTCTGTCCC CCTTGCCGTC CCAAGCAATG 
121  GATGATTTGA TGCTGTCCCC GGACGATATT GAACAATGGT TCACTGAAGA CCCAGGTCCA 
181  GATGAAGCTC CCAGAATGCC AGAGGCTGCT CCCCGCGTGG CCCCTGCACC AGCAGCTCCT 
241  ACACCGGCGG CCCCTGCACC AGCCCCCTCC TGGCCCCTGT CATCTTCTGT CCCTTCCCAG 
301  AAAACCTACC AGGGCAGCTA CGGTTTCCGT CTGGGCTTCT TGCATTCTGG GACAGCCAAG 
361  TCTGTGACTT GCACGTACTC CCCTGCCCTC AACAAGATGT TTTGCCAACT GGCCAAGACC 
421  TGCCCTGTGC AGCTGTGGGT TGATTCCACA CCCCCGCCCG GCACCCGCGT CCGCGCCATG 
481  GCCATCTACA AGCAGTCACA GCACATGACG GAGGTTGTGA GGCGCTGCCC CCACCATGAG 
541  CGCTGCTCAG ATAGCGATGG TCTGGCCCCT CCTCAGCATC TTATCCGAGT GGAAGGAAAT 
601  TTGCGTGTGG AGTATTTGGA TGACAGAAAC ACTTTTCGAC ATAGTGTGGT GGTGCCCTAT 
661  GAGCCGCCTG AGGTTGGCTC TGACTGTACC ACCATCCACT ACAACTACAT GTGTAACAGT 
721  TCCTGCATGG GCGGCATGAA CCGGAGGCCC ATCCTCACCA TCATCACACT GGAAGACTCC 
781  AGTGGTAATC TACTGGGACG GAACAGCTTT GAGGTGCGTG TTTGTGCCTG TCCTGGGAGA 
841  GACCGGCGCA CAGAGGAAGA GAATCTCCGC AAGAAAGGGG AGCCTCACCA CGAGCTGCCC 
901  CCAGGGAGCA CTAAGCGAGC ACTGCCCAAC AACACCAGCT CCTCTCCCCA GCCAAAGAAG 
961  AAACCACTGG ATGGAGAATA TTTCACCCTT CAGATCCGTG GGCGTGAGCG CTTCGAGATG 
1021 TTCCGAGAGC TGAATGAGGC CTTGGAACTC AAGGATGCCC AGGCTGGGAA GGAGCCAGGG 
1081 GGGAGCAGGG CTCACTCCAG CCACCTGAAG TCCAAAAAGG GTCAGTCTAC CTCCCGCCAT 
1141 AAAAAACTCA TGTTCAAGAC AGAAGGGCCT GACTCAGACT GA 
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b. p53 R type mutant gene sequence (R175H   G-A) 
1    ATGGAGGAGC CGCAGTCAGA TCCTAGCGTC GAGCCCCCTC TGAGTCAGGA AACATTTTCA 
61   GACCTATGGA AACTACTTCC TGAAAACAAC GTTCTGTCCC CCTTGCCGTC CCAAGCAATG 
121  GATGATTTGA TGCTGTCCCC GGACGATATT GAACAATGGT TCACTGAAGA CCCAGGTCCA 
181  GATGAAGCTC CCAGAATGCC AGAGGCTGCT CCCCGCGTGG CCCCTGCACC AGCAGCTCCT 
241  ACACCGGCGG CCCCTGCACC AGCCCCCTCC TGGCCCCTGT CATCTTCTGT CCCTTCCCAG 
301  AAAACCTACC AGGGCAGCTA CGGTTTCCGT CTGGGCTTCT TGCATTCTGG GACAGCCAAG 
361  TCTGTGACTT GCACGTACTC CCCTGCCCTC AACAAGATGT TTTGCCAACT GGCCAAGACC 
421  TGCCCTGTGC AGCTGTGGGT TGATTCCACA CCCCCGCCCG GCACCCGCGT CCGCGCCATG 
481  GCCATCTACA AGCAGTCACA GCACATGACG GAGGTTGTGA GGCACTGCCC CCACCATGAG 
541  CGCTGCTCAG ATAGCGATGG TCTGGCCCCT CCTCAGCATC TTATCCGAGT GGAAGGAAAT 
601  TTGCGTGTGG AGTATTTGGA TGACAGAAAC ACTTTTCGAC ATAGTGTGGT GGTGCCCTAT 
661  GAGCCGCCTG AGGTTGGCTC TGACTGTACC ACCATCCACT ACAACTACAT GTGTAACAGT 
721  TCCTGCATGG GCGGCATGAA CCGGAGGCCC ATCCTCACCA TCATCACACT GGAAGACTCC 
781  AGTGGTAATC TACTGGGACG GAACAGCTTT GAGGTGCGTG TTTGTGCCTG TCCTGGGAGA 
841  GACCGGCGCA CAGAGGAAGA GAATCTCCGC AAGAAAGGGG AGCCTCACCA CGAGCTGCCC 
901  CCAGGGAGCA CTAAGCGAGC ACTGCCCAAC AACACCAGCT CCTCTCCCCA GCCAAAGAAG 
961  AAACCACTGG ATGGAGAATA TTTCACCCTT CAGATCCGTG GGCGTGAGCG CTTCGAGATG 
1021 TTCCGAGAGC TGAATGAGGC CTTGGAACTC AAGGATGCCC AGGCTGGGAA GGAGCCAGGG 
1081 GGGAGCAGGG CTCACTCCAG CCACCTGAAG TCCAAAAAGG GTCAGTCTAC CTCCCGCCAT 
1141 AAAAAACTCA TGTTCAAGAC AGAAGGGCCT GACTCAGACT GA 
 
Figure 1. Sequences of a) p53 wild type and b) R type mutant genes. All the bases 
between the two primers (marked in red) are amplified by PCR. The total number of amplified 
bases is 545 for both the p53 wild and R type mutant. On line 481, three bases are highlighted in 
black to indicate the position of the mutation: the three highlighted bases are CGC in the wild 
type and CAC in the R type mutant.  
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2.2.2 Crystal preparation 
The gold-coated quartz crystals having a fundamental resonant frequency of 5 MHz were 
first cleaned in an ultra violet ozone chamber for 10 minutes and then cleaned in a 5:1:1 mixture 
of deionized water, ammonium hydroxide, and sodium peroxide at 74°C for 5-8 minutes. They 
were then washed with deionized water and dried with nitrogen gas. It was again placed in the 
UV ozone chamber for 10 minutes to oxidize any organic impurities present on the crystal 
surface before the surface was modified with the biotin-thiol molecule.   
2.2.3 Formation of the biotin-thiol, streptavidin and ssDNA layers and data collection 
The crystals were soaked overnight in a solution of biotin-terminated tri(ethylene 
glycol)hexadecanethiol (concentration of 1 mM in anhydrous ethanol). They were then washed 
three times with anhydrous ethanol and deionized water and dried with nitrogen gas. A 
monolayer of the biotin-thiol was deposited onto the surface via a covalent bond between the 
thiol group and the gold. The biotin end of the molecule was directed away from the surface 
forming a biotin surface on the crystal (Figure 2a). The resonant frequency and energy 
dissipation data were collected and processed by a commercial module (Q-sense E1). All 
measurements were made in PBS (pH 7.4) at a constant temperature of 23°C. The crystals were 
checked for the resonant frequency for odd harmonic resonances (1 to 13) in the aqueous phase 
before any measurements were made. The flow rate of PBS was kept at 200 µl/min. After 
obtaining a stable frequency baseline in PBS, streptavidin (1 µM in PBS, purchased from Sigma 
Aldrich) was flowed over the crystal (Figure 2b). The fast irreversible binding of streptavidin 
and biotin was confirmed by a sharp decrease in the resonate frequency of the crystals. The 
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biotinylated ssDNA sample was then flowed over the streptavidin layer to which the biotin end 
of the ssDNA binds (Figure 2c and 2d). 
 
 
 
Figure 2. Schematic process for immobilizing ssDNA strands with a complex 3-D 
structure on a quartz crystal a) A monolayer of biotin-thiol is immobilized onto the Au film by 
covalently linking the thiol group to Au. b) A layer of streptavidin binds to the biotin layer. c) 
Biotinylated mutant type ssDNA with a complex 3-D structure is immobilized through binding 
with the streptavidin layer. d) Biotinylated wild type ssDNA (with a different 3-D structure from 
the mutant type) is immobilized onto the crystal by the same method.  
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2.3 RESULTS AND DISCUSSION 
The scheme for immobilizing ssDNA stands, amplified from either the wild type or 
mutant type, on the surface of the resonator is presented in Figure 2. The quartz crystal resonator 
is coated with a thin gold (Au) film.  A monolayer of biotin modified with a thiol functional 
group (biotin-thiol) is first immobilized onto the Au film by covalently linking the thiol group to 
Au (Figure 2a). A layer of streptavidin then binds to the biotin layer (Figure 2b). Afterwards, 
ssDNA with a biotin group at the 5’ end (biotinylated ssDNA) is immobilized through binding 
with the streptavidin layer (Figure 2c and Figure 2d). The biotinylated ssDNA is produced by 
amplifying a fragment of the p53 gene with a biotin-modified primer, followed by denaturing the 
amplified dsDNA at 95oC and suddenly cooling at -20°C. Upon the sudden temperature quench, 
each ssDNA strand undergoes intra-base pairing and forms a particular complex 3-D structure 
which is characteristic of its base sequence. Because of the presence of the mutant base, ssDNA 
strands amplified from wild type and mutant type genes form different 3D conformations before 
they are tethered to the surface of the resonator, which would eventually result in films of 
different mechanical properties.  
The quartz crystal resonator is driven at its fundamental resonant frequency of 5 MHz in 
PBS buffer. The odd harmonic resonances with resolution down to 1 Hz and the energy 
dissipation of the resonator are recorded as a function of time.  The energy dissipation is given in 
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terms of the dissipation factor D42 which is inversely proportional to the quality factor (Q) and 
defined in terms of energy dissipated versus energy stored in the oscillator as:                                         
oscillator in the storedEnergy  2
noscillatioper  dissipatedEnergy 1
π
==
Q
D
  
              (1)             
Figure 3 shows a typical response of the fifth harmonic frequency (Figure 3a and Figure 
3b) and the energy dissipation (Figure 3c and Figure 3d) of the resonator recorded during the 
immobilization of wild type and mutant type ssDNA strands respectively. The first sharp 
decrease in the resonant frequency and the slight increase in energy dissipation indicate a strong 
binding of streptavidin to the biotin layer on the crystal. The biotin on the crystal binds to two of 
the four binding sites of each streptavidin molecule, thus forming a reasonably rigid layer43,44. 
Upon flowing the ssDNA sample over the crystal, the biotin end of the ssDNA quickly binds to 
the streptavidin present on the crystal surface. This is seen as a large decrease in frequency and a 
more apparent increase in energy dissipation. For both the wild and mutant type ssDNA, the 
frequency decrease due to binding of the ssDNA (Figure 3a and Figure 3b) is about the same, 
indicating that the mass adsorbed is about the same. This is expected as the number of bases for 
the wild type and the mutant type ssDNA are both 545 bases. However, interestingly, 
appreciable differences in the energy dissipation due to binding of the wild type (Figure 3c) and 
the mutant type (Figure 3d) are observed, indicating that the viscoelastic properties of the films 
consisting of the two types of ssDNA strands are different.   
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Figure 3. Plot of raw (blue curve) and fitted (black curve) data for a typical frequency 
response and energy dissipation of the resonator at its fifth harmonic resonance as a function of 
time during the immobilization of the streptavidin layer and the ssDNA film. a) Frequency 
response plot for the wild type sample. b) Frequency response plot for the mutant type sample. c) 
Energy dissipation plot for the wild type sample. d) Energy dissipation plot for the mutant type 
sample. 
 
To extract the viscoelastic properties of the ssDNA films from the frequency response 
and energy dissipation of the resonator, the film is modeled using the Voight model of 
viscoelasticity. The Voight model is represented as a spring and a dashpot in parallel, the spring 
constituting the pure elastic response and the dashpot, the viscous response. The calculation of 
shear modulus of polymer films from the electrical response of the quartz resonator using 
transmission line analysis has been well investigated earlier45-47. A more direct method is the 
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continuum mechanics approach, in which the materials physical properties such as the film shear 
modulus, film viscosity, and film thickness are directly related to the experimentally measured 
resonant frequency change and the energy dissipation response48. Within the framework of 
continuum mechanics, the shear modulus used in the Voight model is a complex shear modulus 
(μ*) which can be written as: 
ηπµµ fi2* += ,                                                                                (2) 
where μ is the elastic shear modulus and η is the shear viscosity of the film. For 
viscoelastic materials, as the strain lags the stress by some amount, describing this behavior by a 
complex shear modulus makes it convenient to separate out the in-phase and out-of-phase stress 
components46. When a shear stress σxy is applied to the film, the stress strain relationship on the 
Voight element is given as follows48:  
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∂
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ηµσ                                                                                            (3) 
where ux is the displacement in the x direction and vx is the velocity in the x direction. μ, 
η, and the thickness of the film can be obtained by solving the wave equation for the propagation 
of bulk shear waves in a viscoelastic medium using appropriate boundary conditions48,49 at each 
layer on the crystal surface and fitting the frequency response and energy dissipation into the 
model. The fitted frequency response and energy dissipation of the resonator according to this 
model are plotted and compared with the raw data in Figure 3, which shows reasonably good 
agreement.  
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Figure 4. Plot of thickness and elastic shear modulus (μ) of ssDNA films obtained from 
the data in Figure 3. a) Film thickness as a function of time for the wild type ssDNA sample. b) 
μ as a function of time for the wild type sample. c) Film thickness as a function of time for the 
mutant type sample. d) μ as a function of time for the mutant type sample.  
 
Figure 4 plots the thickness and μ of the films obtained from fitting the Voight model to 
the raw data. It is obvious that an appreciable difference in the plots of μ can be observed 
between the two types of samples, although the difference in the plot of film thickness is 
insignificant. The most apparent difference in the plot of μ is that after the DNA strands are 
immobilized, μ is about 11 kPa for the wild type sample but is about 28 kPa for the mutant type 
one. To confirm the result, the experiments for both types of samples are each repeated four 
times, and the result is presented in Table 2. It is found that the thickness of the biotin-
streptavidin layer is about 10.0 nm with a standard deviation of 1.6 nm, the total thickness of the 
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film after immobilizing the wild type ssDNA is about 30.0 nm with a standard deviation of 5.6 
nm, and the total film thickness for the mutant type ssDNA is about 36 nm with a standard 
deviation of 3.7 nm. This indicates that no significant difference in the film thickness can be 
observed between the two types of samples, and the two types of DNA strands are immobilized 
on the surface with a similar aerial mass density consistently from experiment to experiment. 
However, μ of the films with immobilized wild type samples is about 13,715 Pa with a standard 
deviation of 1,713 Pa, while μ of the films with immobilized mutant type samples is about 
24,399 Pa with standard deviation of 1,808 Pa. 
The large difference in μ indicates that there is an appreciable difference in the 
viscoelasticity of the films formed by the wild type and mutant type DNA. This difference is 
likely because the two types of ssDNA strands form different 3-D conformations in aqueous 
solution which is the direct result of one base mutation in their sequences. Upon quenching the 
temperature rapidly, ssDNA strands form a complex 3-D structure to minimize its free energy 
and hybridize with itself via intra-base pairing. During this process, even a single base mutation 
may significantly alter the 3-D structure of the ssDNA in solution, which leads to the appreciable 
differences in the mechanical properties of the DNA films formed by tethering such DNA 
strands to a solid surface. The resulted difference in the mechanical properties of the DNA films 
may be detected by a number of techniques. We believe that the example we show here by 
probing the elastic shear modulus of the DNA films using a quartz crystal resonator is only one 
approach among many others.  
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Table 2. Film thickness and shear modulus measured during the immobilization of p53 
wild type ssDNA and the p53 R type mutant ssDNA.  
 
 
Sample 
Film 
thickness: 
         (nm) 
Film Shear 
Modulus 
          (Pa) 
p53 Wild type 
ssDNA 
Expt 1 29.5 15,561 
Expt 2 37.6 14,553 
Expt 3 21.9 10,953 
Expt 4 31.0 13,793 
p53 R type 
mutant ssDNA 
Expt 1 35.9 25,542 
Expt 2 34.3 23,258 
Expt 3 42.1 26,687 
Expt 4 32.1 22,110 
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2.4 CONCLUSIONS 
Although resonator-based sensors have been used for mutation detection 28,29,50-53,  they 
are all based on mass change on the surface of the resonator which serves as a mass balance. 
Such mass change is typically caused by capturing DNA strands through hybridization with a 
DNA probe or use of a bioreceptor. To the best of our knowledge, no literature has reported 
mutation screening based on the mechanical properties of the ssDNA films. Coupling DNA films 
with a resonator provides an excellent means to probe the mechanical properties of DNA films. 
Combining it with the capability of DNA molecules to form unique 3-D structures enables us to 
screen the mutant from wild type DNA quickly and reliably. We have shown the capability of 
this technique to detect a single base mutation among a fragment of 545 bases in p53 gene, 
which already exceeds the reported maximum length of the DNA that can be effectively screened 
by other methods such as SSCP/HA and its variants. This technique can be further improved by 
selecting different fragments of the gene containing the mutation to optimize the screening.  
Similar to all the technologies based on the formation of DNA 3-D complex structures, much 
study still needs to be carried out to understand and predict the 3-D structure of the long DNA 
strand in solution as well as on a solid surface, so that better experiments could be designed to 
maximize the difference in the mechanical properties of the 3-D structures between the wild and 
mutant type DNA. 
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3.0  RAPID DNA-BASED DETECTION OF INFECTIOUS DISEASES  
3.1 NEED FOR RAPID DIAGNOSTIC ASSAYS 
The tremendous advancements made in the healthcare industry especially in the area of rapid and 
reliable diagnosis of diseases have not fully reached the developing and the under-developed 
countries. The need for rapid point of care diagnostics is booming in the developing world 
largely due to the interest shown by the developed countries and world organizations such as the 
WHO to make basic healthcare accessible to the poorest regions of the world. For example, the 
number of child deaths (below 5 years of age) in the year 2008 was estimated to be about 8.8 
million with more than 90% of the deaths occurring in South Asia and Africa. Pneumonia and 
diarrhea account for a third of these deaths. Moreover, children severely affected by malnutrition 
are at a high risk of death due to diarrhea and pneumonia making these the deadliest diseases 
leading to child mortality in the developing world. Although improvements in public health care 
such as better sanitation and safe drinking water are of paramount importance to prevent their 
occurrence, rapid diagnosis of these diseases which are otherwise very treatable is very essential. 
Life threatening diseases such as Gonorrhea and Chlamydia which are highly prevalent in the 
poorest regions of the world could be easily cured if diagnosed correctly at the right time.  
 Ideally point of care diagnostic procedures aimed for the developing world should have 
the following characteristics: 
a) Sensitive and specific: The test should be able to detect all the positives and give few false 
positives. 
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b) Affordable: The test should not require large, expensive machinery and should be 
administered to the public at a low cost.  
c) Rapid: The results of the test should be made available rapidly, typically in only one 
sitting so that treatment can be carried out immediately.  
d) Simple to use: The test should be designed in a way such that inexperienced personnel 
should be able to operate it without too much difficulty.   
 
 Conventionally, DNA-based biosensors are based on hybridization of the 
complementary strand to an immobilized ssDNA probe. Biosensors based on DNA hybridization 
suffer from slow hybridization kinetics when compared to hapten-antibody or antibody-antigen 
binding kinetics. Also, many incomplete hybridization reactions between not fully 
complementary strands produce false positive signals because although not fully complementary, 
the sequences may contain significant portions of complementary sequences. Furthermore, the 
amount of DNA material available from patient samples is typically low and amplification is 
usually necessary. DNA amplification with optimally designed primers labeled with haptens 
such as biotin, FITC, Digoxigenin, etc. amplify the DNA with high specificity and the presence 
of the label makes it easy to detect via hapten-antibody reactions using low cost methods such as 
detection via lateral flow strips.   
Therefore, the success of the DNA biosensor primarily depends on the design of primers, 
which provides the selectivity and the sensitive detection of the labels which is largely dependent 
on the right antibody immobilization technique. We thought it would be worthwhile to 
investigate the right antibody immobilization method for biosensor applications before we delve 
into the detection of amplified DNA products.   
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3.2 CHARACTERIZATION OF ANTIBODY IMMOBILIZATION METHODS 
3.2.1 Introduction 
Biosensors sensors which incorporate antibodies to detect the target molecule (analyte) 
find applications in numerous fields such as medical diagnostics, environmental applications and 
food analysis to name a few 54-56. The high specificity, sensitivity and rapid detection times have 
rightly warranted great interest in the field of antibody based biosensors. The specificity of 
antibodies to single out the target molecule from a complex medium is the biggest driving force 
to engineer antibody based biosensors. But, the reliability of antibody based biosensors has been 
a major issue as immobilization of the antibodies on substrates tends to make them inactive, as a 
result of which the antibody loses its ‘biosensing’ ability.  The reasons for inactivity could be 
due to the denaturing of the antibodies on the surface or because of the unfavorable orientation of 
the surface antibodies wherein the antibody is unable to bind to the antigen. With different 
populations of the immobilized antibodies rendered inactive, the sensitivity becomes inconsistent 
and it also becomes difficult to study the kinetics of the antibody-antigen interaction 57. These 
factors are major hindrances to the development of sensitive, miniaturized biosensors.   
Antibodies contain two light chains and two heavy chains which form a “Y” shaped 
structure 58. The amino acid sequence at the tips of the “Y” shaped antibody molecule, for both 
the heavy chain as well as the light chain, is variable, which gives it the high affinity and 
specificity to bind to the antigen. The Fc region of the antibody contains carbohydrate molecules 
which could be used to anchor the antibody to substrates in a way that the antigen binding 
domain is free to bind antigen. Immobilization of the antibodies by physical adsorption using the 
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van der Waal’s forces is probably the simplest, but studies have shown that antibodies denature 
when immobilized this way 59,60. Immobilizing antibodies by covalent attachment 61-63 to 
surfaces is robust and efficient, but may cause denaturing or the antibody may be immobilized 
with its active sites blocked.  
  A number of research articles have been written confirming that oriented immobilization 
of antibodies is better suited to capture antigens than randomly oriented antibodies64-68. The 
kinetic rate constants of antibody-antigen interactions have been studied using labeled techniques 
such as fluorescence based fiber-optic biosensor57, TMB substrate assay69 and label free 
techniques such as surface plasmon resonance (SPR)70 and quartz crystal microbalance 
(QCM)63,71, but to our knowledge, none have described the equilibrium binding kinetics in detail.     
The choice of the right immobilization method for biosensor applications depends not only on 
the amount of freely available antibodies on the surface [Abo] and the association equilibrium 
constant Ka, but also on the concentration of the antigen that needs to be detected.  The QCM’s 
real time mass sensitivity, reliability and ease of surface modification make it an excellent choice 
to probe the equilibrium kinetics of antibody-antigen binding. It can measure extremely low 
masses (ng/cm2) with very high precision by accurately measuring the decrease in the resonant 
frequency of the quartz crystal when mass is deposited on it. The frequency of resonance of the 
quartz crystal decreases linearly with the mass adsorbed according to the Sauerbrey equation and 
a very accurate and sensitive measurement of mass adsorbed can be made.  
In this work, we examine some of the most commonly used techniques to immobilize 
antibodies and provide a quantitative means to evaluate the different immobilization chemistries 
and their associated heterogeneities when immobilized. We have studied the immobilization of 
Mouse IgG antibody (antibody) via three different immobilization schemes and its interaction 
with Anti-Mouse IgG antibody (antigen). Mouse IgG antibodies were immobilized by covalent 
attachment to the substrate (randomly oriented), attachment via Protein A which specifically 
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binds to the Fc region of the antibody (partially oriented) and finally, attachment by biotinlyated 
antibody to a streptavidin covered substrate (fully oriented). Equilibrium adsorption studies were 
conducted for each of the immobilization chemistries using the QCM. The equilibrium 
adsorption isotherm between the antibody and antigen follows the conventional Langmuir 
adsorption model, from which we can obtain useful information about the association 
equilibrium constant (Ka) and the surface concentration ([Abo]) of active antibody. Also, the 
equilibrium data has been fitted to the Sips isotherm from which we can gain information about 
the surface heterogeneity of the immobilized antibody and the validity of the Langmuir isotherm. 
The Sips isotherm also provides us with the Ka and [Abo] for the adsorption experiments. From 
the results of our work, it is evident that the best method of immobilization depends not only on 
the amount of freely available active binding sites on the surface and the association equilibrium 
constant which are totally dependent on the immobilization method, but also on the 
concentration range of the antigen. For lower concentrations of the antigen, we find that the three 
methods of immobilization are comparable, whereas for higher antigen concentrations, oriented 
immobilization gives better results.  
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3.2.2 Experimental details 
Materials 
Mouse IgG antibody, Antimouse IgG antibody produced in goat, Protein A from Staphylococcus 
aureus, streptavidin were purchased from Sigma Aldrich Chemicals, MO. Biotin-PEG4-
Hydrazide and Dithiobis succinimidylpropinonate (DSP) was purchased from Thermo Fischer. 
Biotin-terminated tri (ethylene glycol)hexadecanethiol was purchased from Assemblon. Gold 
coated quartz crystals having a resonance frequency of around 5 MHz were purchased from Q-
sense. Dimethylsulfoxide (DMSO) was purchased from Fisher chemicals, Phosphate buffer 
saline (PBS) was used throughout unless specified. Ammonium hydroxide and sodium peroxide 
solutions were used to clean the gold coated quartz crystals.  
 
Crystal preparation and data collection 
The gold coated quartz crystals were cleaned by first placing them in a UV ozone chamber for 15 
minutes to oxidize any organic impurities present on the surface.  It was then treated with a 5:1:1 
solution of deionized water, ammonium hydroxide and sodium peroxide at 74 oC for 10 minutes. 
The crystals were washed with DI water and placed in the UV ozone chamber for another 10 
minutes before any surface modification was made.  The resonant frequency of the quartz crystal 
was measured in a commercial QCM (Q-sense E1). All experiments were carried out in PBS at a 
flowrate of 100 µL/min at 230 C. The crystals were checked for the resonant frequency for the 
odd harmonics (1 to 13) in PBS and the frequency was allowed to stabilize before the adsorption 
data was collected.  
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Direct covalent immobilization 
Covalent attachment of proteins to surfaces like glass or gold is rapid and inexpensive. It can be 
carried out by amine chemistry (by functionalizing the surface with active NHS esters or 
aldehydes), thiol chemistry (by maleimide, disulfide or vinyl sulfone functionalized surfaces) or 
by carboxyl chemistry using carbodiimde activation 61,62,72. Mouse IgG antibody was covalently 
immobilized on the gold coated quartz crystal using amine chemistry by functionalizing the gold 
surface of the quartz crystal with active NHS ester groups. The disulfide linkage in DSP rapidly 
attaches to the gold surface and the NHS ester moiety reacts with the free amine groups present 
on the antibody surface to form stable amide bonds. The cleaned gold coated quartz crystals are 
immersed in DSP at a concentration of 4 mg/mL in DMSO for 30 minutes at room temperature 
and then rinsed with DMSO and water three times. It is then immediately immersed in the 
antibody solution (Mouse IgG) of concentration 0.05 mg/mL for 4 hours to link it to the gold 
surface.  The gold crystals are then washed with PBS buffer to remove the cross linker 
byproducts and the unconjugated antibody before being loaded into the QCM. The scheme of 
immobilization of the antibody via covalent attachment is presented in Figure 5a. Antigen 
solutions (Antimouse IgG produced in goat) of concentrations ranging from 1 nM to 100 nM are 
allowed to bind to the Mouse IgG present on the surface. After the binding has reached 
equilibrium, it is washed with PBS and the amount of antigen bound on the surface for each 
concentration of the antigen in solution is evaluated by measuring the decrease in the resonant 
frequency of the QCM.   
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Immobilization via Protein A 
Protein A is a coat protein extracted from the bacterium Staphylococcus aureus which can 
specifically bind to the Fc region of IgG class of antibodies. Although Protein A, Protein G and 
Protein L all exhibit specific binding to IgG class of antibodies, Protein A was chosen to 
immobilize Mouse IgG antibody as it binds to Mouse IgG strongly whereas its binding to the 
Antimouse IgG antibody produced in goat is weak. This reduces the possibility of Antimouse 
IgG antibody to bind to the some unbound Protein A sites on the surface. As Protein A binds to 
the Fc region of the antibody specifically, the antigen binding domain of the antibody is free to 
bind to the antigen. This makes this scheme of immobilization more oriented with respect to the 
antibody as opposed to immobilizing the antibody randomly on the crystal surface (Figure 5b).  
Protein A is covalently attached to the gold coated quartz crystal using amine chemistry as 
described in detail previously.  The crystal with Protein A immobilized on the surface is loaded 
into the QCM’s flow module and antibody (Mouse IgG) solution of concentration 0.05 mg/mL is 
allowed to bind to the Protein A. Once the surface is saturated, antigen (Antimouse IgG 
antibody) solutions of concentrations ranging from 1 nM to 100 nM are allowed to bind to the 
antibody present on the surface and the data is evaluated as before. 
  
Immobilization via biotinylated antibody on a streptavidin coated surface 
Biotin is a B-complex vitamin molecule which has a very strong affinity for the protein 
streptavidin and its variants avidin and neutravidin.  Biotin can be specifically attached to the Fc 
region of the antibody 57,73  and when the antibody is immobilized onto a streptavidin coated 
surface, the antigen binding domain of the antibody is free to bind to the antigen. Carbohydrates 
are present on the antibody’s Fc region which can be oxidized to form aldehydes which when 
reacted with biotin hydrazide, labels the antibody with biotin specifically at the Fc region. The 
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detailed protocol to label the antibody with biotin can be found with Thermo Fisher. Instead of 
using 2 mg/mL of the protein solution, 0.05 mg/mL of antibody (Mouse IgG) solution in PBS 
was used. Cleaned gold coated quartz crystals were soaked overnight in a solution of biotin-
terminated tri (ethylene glycol)hexadecanethiol at a concentration of 1 mM in anhydrous ethanol. 
A self assembled monolayer (SAM) of the biotin-thiol is deposited via a covalent bond between 
the thiol and the gold surface with the biotin moiety directed away from the surface forming a 
monolayer of biotin on the crystal surface (Figure 5c). The crystal with the SAM was loaded 
into the flow module of the QCM and streptavidin of concentration 1 μM in PBS was allowed to 
bind to the biotin on the crystal surface.  The biotin on the crystal binds to two of the four 
binding sites of each streptavidin molecule, thus forming a reasonably rigid layer 44,74. The 
excess streptavidin was washed by rinsing with PBS and the biotinylated antibody (Mouse IgG), 
concentration 0.05 mg/mL was flowed over the streptavidin layer to which it binds rapidly and 
irreversibly.  It is rinsed again to remove any loosely bound antibody and then antigen 
(Antimouse IgG antibody) of concentrations ranging from 1 nM to 120 nM are allowed to bind 
to the Mouse IgG present on the surface and the data was evaluated.  
 
 
 
 32 
 
 
Figure 5. Schematic of the immobilization chemistries a) Direct covalent immobilization 
of the antibodies (Mouse IgG) on the crystal surface. The crystal surface is first functionalized 
with NHS ester and the antibodies are immobilized randomly on the surface. Antigen 
(Antimouse IgG) binds to only those antibodies which have favorable orientation. b) 
Immobilization of the antibodies (Mouse IgG) on the crystal surface via Protein A. The crystal 
surface is first functionalized with NHS ester and Protein A is immobilized randomly on the 
surface. Antibodies (Mouse IgG) bind specifically at the Fc region to the Protein A. Antigen 
(Antimouse IgG) binding is more efficient as the antibodies have their antigen binding domain 
free. c) A self assembled monolayer of biotin thiol is formed on the crystal surface onto which 
streptavidin binds. The antibodies (Mouse IgG) are labeled with biotin at the Fc region which 
then binds to the streptavidin on the surface. Antigen binding (Antimouse IgG) is depicted in the 
last schematic. 
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3.2.3 Results and discussion 
Sauerbrey equation to estimate the adsorbed mass 
The Sauerbrey equation relates the amount of mass adsorbed onto the quartz crystal linearly with 
the resonant frequency decrease of the quartz crystal. It is given as:  
m
A
ff
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−
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µρ
2
02                                                                                                                                   (4)       
where fo is the resonant frequency in Hz, Δf is the frequency change in Hz,  Δm is the mass 
change in grams, A is the piezoelectrically active crystal area in cm2, ρq  is the density of quartz 
(ρq = 2.648 g/cm3) and μq is the shear modulus of quartz for AT-cut crystal 
(μq =2.947x1011 g/cm.s2).  
The above equation is only valid when the adsorbing film is thin when compared to the 
thickness of the quartz 75. Protein films are generally soft films which dissipate energy through 
them as the film is not completely coupled to the quartz crystal. But when the dissipation factor 
(D factor), which is a measure of the energy dissipated through the film is not high it is sufficient 
to use the Sauerbrey equation to estimate the mass adsorbed.  The Sauerbrey equation is applied 
to the 5th overtone of the resonant frequency of the quartz crystal and the mass adsorbed is 
calculated in ng/cm2. 
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Adsorption isotherms 
The equilibrium adsorption for antibody-antigen (Ab-Ag) binding can be very conveniently 
described by the Langmuir adsorption isotherm. The Langmuir adsorption isotherm is very 
useful to describe monolayer adsorption which is limited by the equilibrium between the 
concentration of the species in solution and the concentration of the species adsorbed on the 
surface. In addition to a monolayer adsorption, the Langmuir isotherm assumes that each binding 
site can accommodate only one molecule and all the sites are energetically equivalent with no 
interaction between the species adsorbed. The Langmuir isotherm relates the concentrations of 
the species adsorbed to the concentration of the species in solution in the following way:  
Ab: Antibody, Ag: Antigen, AbAg* is the Antibody-Antigen complex 
*AbAgAgAb →+                                                                                                                                  (5)                     
[ ][ ]AgAbkr onf =                                                                                       (6)            
[ ]*AbAgkr offb =                                                                    (7)               
where kon is the association kinetic constant and koff is the dissociation kinetic constant. 
At equilibrium, bf rr = and defining the association equilibrium constant
off
on
a k
kK = , 
we have:  
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[ ] [ ] [ ]*AbAgAbAb o +=                  (9) 
where [ ]oAb is the total number of available binding sites and [Ab] is the number of 
unbound binding sites.     
[ ] [ ] [ ][ ]AgK
AgAbKAbAg
a
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+
=
1
*                                                                (10) 
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Other adsorption isotherms based on the Langmuir isotherm such as the Sips isotherm 
(Langmuir-Freundlich isotherm) have also been used to describe the equilibrium binding kinetics 
of antibody-antigen in both solution and on the surface 76,77. The Sips isotherm is similar to the 
Langmuir isotherm but it assumes that the adsorption sites have energies ranging from 0 to ∞. It 
is given by:   
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*                                              (11) 
The index s is a measure of the surface heterogeneity of the adsorbed antibody. When antibodies 
are immobilized onto a substrate, some of them lose their functionality and thus the layer is 
heterogeneous with respect to the antigen binding ability. The low concentration limit of the 
adsorption isotherm (at low antigen concentrations) is dependent on the high affinity tail of the 
affinity distribution. The parameter s is a measure of how quickly the affinity tail decays. When s 
> 1, the tail decays rapidly and the adsorption follows the Langmuir isotherm. But when the 
value of s < 1, the tail of the affinity distribution curve decays slowly and the distribution of the 
antibodies which are capable of binding the antigen is spaced farther out. The value of s = 1, is 
the crossover point beyond which Langmuir Isotherm is sufficient to describe the binding 
between the antibody and antigen.  
The amount of antigen adsorbed is evaluated for different concentration of the antigen in 
solution and the double reciprocal plot of equation 10 gives us a straight line with slope = 
[ ] ao KAb
1  and intercept =   [ ]oAb
1 . For the Sips isotherm (equation 11), the curve was fitted to 
three parameters [Abo], Ka and s using nonlinear regression in MATLAB’s curve fitting tool 
box. In the following section, the results of the three immobilization strategies are discussed in 
detail. 
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Direct covalent immobilization 
Figure 6a shows the resonant frequency change with time (blue curve) when Antimouse IgG 
(antigen), of concentration 60 nM binds to Mouse IgG (antibody) immobilized randomly by 
amine chemistry. The sharp frequency decrease initially shows the high binding affinity of 
Antimouse IgG to Mouse IgG present on the surface and the slower binding after the initial 
period shows that the binding is controlled by the equilibrium between Antimouse IgG in the 
solution and Antimouse IgG adsorbed on the surface. The large reservoir of Antimouse IgG 
solution is recycled and thus, this concentration of the solution can be assumed to be the 
concentration of the Antimouse IgG at equilibrium. The amount of antigen bound to the surface 
is directly proportional to the frequency decrease and is evaluated by the Sauerbrey equation 
(Equation 4) and a real time plot of amount of antigen adsorbed (Antimouse IgG) is shown in 
Figure 6a (black curve). The amount adsorbed is calculated for solution antigen concentrations 
ranging from 1 nM to 100 nM and fitted to the Langmuir (Figure 7a) and Sips adsorption 
isotherm (Figure 7b). The solid lines represent the curve fitted to the average values (from three 
experiments) of [Abo] and Ka and individual data points are plotted on this curve with the error 
bars representing the standard error. The average values of [Abo] and Ka evaluated from the 
Langmuir isotherm and Sips isotherm are presented in Table 3 and Table 4. The degree of 
heterogeneity of the adsorbed antigen layer can be assessed by the parameter s in the Sips 
isotherm and is found to be 0.75± 0.04 which indicates that the antibody immobilized onto the 
surface is highly heterogeneous due to its random orientation.       
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Immobilization via Protein A 
Figure 6b shows the resonant frequency change (blue curve) for the antibody (Mouse IgG) 
binding to Protein A on the crystal surface with time. The second marked decrease in Figure 6b 
is when, after saturating the surface with the antibody, antigen of concentration 100 nM is 
allowed to bind to the antibody.  A real time plot of mass adsorbed is presented (black curve), 
from which the amount of antigen adsorbed on the surface can be evaluated. The amount of 
antigen adsorbed is evaluated for solution antigen concentrations ranging from 1 nM to 100 nM 
and is fitted to the Langmuir and Sips adsorption isotherm. [Abo] and Ka are evaluated for both 
adsorption isotherms as discussed before and are presented in Table 3 and Table 4. The 
heterogeneity of the adsorbed antibody (s) is greater than 1 showing that this scheme of 
immobilization is highly ordered. 
 
Immobilization via biotinylated antibody on a streptavidin coated surface.  
Figure 6c shows the frequency decrease (blue curve) for the binding of streptavidin, biotinylated 
antibody and antigen, of concentration 40 nM respectively. The mass adsorbed in each case is 
calculated using the Sauerbrey equation and the mass deposited is plotted with time (black 
curve). The data for amount of antigen adsorbed on the surface is evaluated for solution antigen 
concentrations ranging from 1 nM to 120 nM and as before, the [Abo] and Ka are calculated 
using the Langmuir (Table 3) and Sips (Table 4) adsorption isotherm and s>1 represents a 
highly homogeneous surface.    
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Figure 6. a) Direct covalent immobilization: Plot of frequency change (blue curve) and 
Sauerbrey mass calculated for the 5th overtone   (black curve) with time for the adsorption of 
Antimouse IgG. b) Via Protein A: Plot of frequency change (blue curve) and Sauerbrey mass 
calculated for the 5th overtone   (black curve) with time for the adsorption of Mouse IgG and 
subsequently, Antimouse IgG. c) Via biotinylated antibody: Plot of frequency change (blue 
curve) and Sauerbrey mass calculated for the 5th overtone   (black curve) with time for the 
adsorption of streptavidin, biotinylated Mouse IgG and Antimouse IgG.  
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Table 3. Summary of results for the three immobilization chemistries for Langmuir 
adsorption isotherm. The average values for three experiments of [Abo] and Ka are presented 
here with the standard error.   
 
                                                   
LANGMUIR ADSORPTION ISOTHERM 
 
Immobilization method [Abo] 
(ng/cm2) 
 
Ka (*108) 
(1/M) 
Direct covalent immobilization 1726 ± 18 3.71 ± 0.20 
Immobilization via Protein A 2683 ± 58 0.62 ± 0.01 
Immobilization via biotinylated antibody   2120± 34 
 
2.68± 0.13 
 
 
 
Table 4. Summary of results for the three immobilization chemistries for Sips adsorption 
isotherm. The average values for three experiments of [Abo], Ka and s are presented here with 
the standard error.   
                            
                               SIPS ADSORPTION ISOTHERM 
 
Immobilization method 
 
[Abo] 
 (ng/cm2) 
 
Ka (*108) 
(1/M) 
s 
Direct covalent immobilization 1846± 36 3.11± 0.31 0.75± 0.04 
Immobilization via Protein A 2621±  74 0.73± 0.02 1.25± 0.01 
Immobilization via biotinylated antibody 2040± 23 2.69± 0.12 1.33± 0.09 
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Figure 7. a) Langmuir adsorption isotherm and the b) Sips adsorption isotherm for all 
three immobilization schemes. 
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3.2.4 Conclusions 
Two major inferences can be drawn from the equilibrium adsorption data fitted to the 
adsorption isotherms. Firstly, we can see that when the antibody is immobilized onto the quartz 
crystal surface directly using amine chemistry, the total surface concentration of active 
immobilized antibody, [Abo] is the lowest. This is expected when the antibodies are immobilized 
randomly, due to which they do not possess a favorable orientation to bind the antigen. [Abo] is 
the highest for immobilization via Protein A, as the antibodies have their antigen binding 
domains free and most of them have a favorable orientation to bind the antigen. Immobilization 
via biotinylated antibodies on a streptavidin coated surface is the most oriented scheme, but does 
not give the highest [Abo] probably due to excessive chemical modification of the antibody 
during biotinylation, which may have denatured the antibody.   
Secondly, Ka which represents how much of the unbound active antibodies are able to 
form the antibody-antigen complex at equilibrium is the highest for random covalent 
immobilization. This is because although [Abo] is lower than the other schemes, the ones which 
are indeed active, are able to bind the antigen to a high degree due to lower steric hindrance 
offered by the antibodies to antigen binding as compared to the other schemes. Even though 
[Abo] for immobilization via Protein A is the largest, steric hindrance prevents the antigen from 
binding to the antibody on the surface and therefore has the lowest value of Ka.   
The association equilibrium constant dominates over the total available binding sites at 
lower antigen concentrations, whereas nearing saturation, the total amount of available binding 
sites [Abo] becomes important.  This is evident from Figure 7a and Figure 7b, where at low 
solution antigen concentrations of about 3 nM, the amount of antigen bound to the surface via 
Protein A is less than half than the other two methods. At intermediate antigen concentrations of 
around 18 nM for the Langmuir isotherm and 14 nM for the Sips isotherm, the amount of antigen 
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bound by direct covalent immobilization and immobilization via Protein A is equal but lesser 
than the amount bound by the biotinylated labeled antibody. At concentrations nearing the 
saturation concentration of the antigen, we see that immobilization of the Mouse IgG antibody 
by Protein A binds the highest amount of antigen.  Therefore, at higher concentrations the 
random orientation of the antibodies immobilized by direct covalent immobilization gives rise to 
a large number of inactive antibodies on the surface which is not capable of binding the antigen. 
Immobilization of antibody using Protein A gives the maximum amount of active antibodies on 
the surface as Protein A has a natural affinity to the Fc region of antibodies which does not 
adversely affect the antibody’s antigen binding ability. Although Protein A is immobilized 
randomly on the surface using direct covalent chemistry, it still gives the highest amount of 
active antibodies on the crystal surface at saturation. In reality, the most oriented scheme of 
immobilization investigated here is the biotinylated antibody which binds to an ordered layer of 
streptavidin which is in turn bound to an ordered self assembled monolayer of biotin thiol. Yet, 
the antibodies immobilized this way do not give the highest amount of antigen binding at 
saturation concentrations of the antigen which may be due to the excessive chemical 
modification of the antibody to label it with biotin. Therefore, when considering the choice for 
the immobilization scheme, the antigen or target molecule’s concentration range becomes 
essential. At low concentrations, where the Ka dominates the antibody-antigen binding, direct 
covalent immobilization is adequate, whereas at higher antigen concentrations, [Abo] dominates 
the equilibrium binding and an oriented immobilization scheme performs better. 
 43 
3.3 RAPID POINT-OF-CARE DETECTION OF INFECTIOUS DISEASES USING 
LATERAL FLOW TECHNOLOGY  
3.3.1 Introduction 
Escherichia coli (E. coli) are one of the main components of the normal bacterial flora of 
the large intestine of mammals78,79. However, E. coli also may be the causative agent of several 
extra-intestinal infections besides the more common intestinal infections, such as travelers’ 
diarrhea and hemorrhagic diarrhea 80-82. Amongst the various extra-intestinal infections, E. coli is 
the most common cause of urinary tract infections (UTI) as well as several life threatening 
conditions including neonatal meningitis and sepsis 83,84.  
Shiga toxigenic E. coli are bacteria responsible for severe gastrointestinal infections in humans. 
There are certain strains which are more virulent than others, for example, the STX-1 and STX-2 
strains. Furthermore, a combination of the two strains is known to cause greater harm leading to 
cases of hemolytic-uremic syndrome (HUS) and thrombotic thrombocytopenic purpura 85,86. 
Large outbreaks of gastrointestinal disease caused by these strains and their high mortality rates 
in developing countries have placed their timely detection and diagnosis high on the priority list 
for communicable diseases.      
Klebsiella pneumoniae (K. pneumoniae) is another gram negative bacterium which is 
present in the colon. It is second leading cause of UTI and is responsible for a number of other 
infections such as pneumonia, septicemia and neonatal sepsis 87,88 . Klebsiella pneumoniae, the 
most important Klebsiella species is an opportunistic pathogen which causes infections 
associated with hospitalization. Immuno-compromised individuals are more susceptible to K. 
pneumoniae infections and the high mortality rates and the surge of antibiotic resistant strains 
have renewed interest in the rapid early diagnosis of K. pneumoniae. 
 44 
   
Currently, diagnosis of most extra-intestinal infections caused by bacteria including E. 
coli is made by bacterial culture which often takes at least 24-48 hours. Newer DNA 
amplification based techniques like PCR can give results much faster but are not widely used for 
diagnosis of bacterial infection, in part because they require considerable operator skill and 
expensive equipment. Recently, a novel, specific, and rapid technique for amplification of DNA 
under isothermal conditions has been reported 89,90. This technique, termed Loop mediated 
isothermal amplification (LAMP) requires a constant temperature condition throughout the 
reaction, ranging from 62-66 oC for a period of 30-60 minutes. Thus, LAMP can be conducted 
on a simple heating block, obviating the need for an expensive thermal cycling machine such as 
required for PCR. In this study, we developed and characterized LAMP primers and 
amplification protocols for E. coli malB, E. coli STX-1 and K. pneumoniae. The amplification 
products can be detected visually by observing the fluorescence upon addition of a DNA 
intercalating dye such as Eva Green, Sybr Green, Ethidium Bromide or Propidium Iodide 91. The 
appearance of turbidity has also been made use for detection of the amplified product 92. More 
recently, DNA based lateral flow assays in which two small molecule labels, one which binds to 
reporter particles and the other which binds to the nitrocellulose membrane are made use of in a 
sandwich type format after amplification by LAMP 93-96. Lateral flow strips offer a low-cost, 
sensitive and instrumentation free detection method. We report the details of LAMP 
amplification of E. coli malB, E. coli STX-1 gene and K. pneumoniae citw along with the 
detection on lateral flow strips using a set of anonymized human biological specimens. 
Multiplexing detection of two organisms has also been successfully demonstrated.  The results of 
the LAMP/Lateral flow detection were compared with PCR as well as bacterial culture results.     
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3.3.2 Detection on lateral flow strips 
A typical lateral flow strip consists of a porous membrane usually made of nitrocellulose, 
sample and absorbent pads assembled on an adhesive backing strip which provides structural 
integrity to the membrane along with the other components. Sometimes, a conjugate pad is also 
included on which the reporter particles are deposited. Colloidal gold nanoparticles (15-80 nm) 
are the most commonly used reporter particles due to their optical properties in the nanometer 
scale and the ease of functionalizing the surface with antibodies and other biomolecules such as 
DNA and RNA. Other particles such as latex 97, carbon black 98,99, liposomes 100,101 and Up-
Converting Phosphur (UCP) 102 have also been used in lateral flow assays. Initially, detection 
was carried out using enzymatic labels such as in ELISA 103, but now, reporter particles such as 
the ones mentioned above offer higher stability than the enzymatic labels.  The sample pad helps 
to draw the sample solution on to the nitrocellulose membrane and the absorbent pad helps to 
wick the sample and the reporter particles towards the end of the strip.  In a typical sandwich 
type immunoassay, the target sample is allowed to bind to the reporter particles in the presence 
of a flow buffer and travels along the membrane via the action of capillary forces. If the target is 
present in the sample, the reporter particle-target complex binds to the test line making possible 
for visual detection in the case of gold nanoparticles or detection via a detector. Sometimes, the 
remaining reporter particles which do not bind the test line travel further downstream to bind to 
the control line, to which the reporter particles bind directly. 
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3.3.2.1 Principle of detection of amplified DNA on lateral flow strips 
 
The DNA amplified either by PCR or LAMP must contains two labels, which in the case 
of E. coli malB is chosen to be FITC and biotin and for E. coli STX-1 and K. pneumoniae is 
chosen to be Digoxigenin and biotin (Figure 8a). This is mixed with the GNPs conjugated with 
streptavidin (Figure 8b) to which the biotin label on the amplified DNA binds (Figure 8c). The 
DNA-GNP complex is applied to the sample pad and is flowed onto the membrane. The FITC 
label on the amplified E. coli malB DNA binds to the Anti-FITC antibody on the membrane and 
the E. col malB-GNP complex aggregate at the test line (Figure 8d). Thus, for a successful 
positive assay to be detected visually, a two layer sandwich structure, namely the binding 
between biotin present on the DNA to streptavidin on the GNPs and FITC on the DNA with 
Mouse Anti-FITC on the membrane is needed. The unbound GNPs which are conjugated with 
streptavidin directly bind to a secondary antibody (Anti-streptavidin) present on the control line. 
The aggregation of the colloidal gold on the control line shows that the streptavidin present on 
the GNPs is capable of binding. If the control line is not bound by the GNPs, the assay must be 
disregarded as the cause for a negative test line and control line could be due to the denaturing of 
the streptavidin rather than the absence of target DNA in the sample solution. Similarly for the 
case of E. coli STX-1 and K. pneumoniae, a two layer sandwich structure between the biotin label 
to streptavidin on the GNPs and the Dig label on the amplified DNA to the Anti-Dig antibody on 
the membrane is required.  
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Figure 8. Schematic of binding events on a lateral flow strip for labeled amplified DNA 
detection  a) FITC (green) and Biotin (yellow) labeled amplified E. coli malB dsDNA and 
Digoxigenin (blue) and Biotin (yellow) labeled amplified E. coli STX-1/K. pneumoniae. b) 
Schematic of streptavidin coated GNP. c) Streptavidin coated GNP binds to the Biotin label on 
the amplified DNA product. d)  Schematic of a positive test for E. coli malB (top) and E. coli 
STX-1/K. pneumoniae (bottom).  
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3.3.2.2 Preparation of lateral flow strips 
 
We have investigated four different lateral flow strip nitrocellulose membranes which are shown 
in Table 5 with their properties.  
 
Table 5. List of nitrocellulose membranes. (Capillary rise is measured as the time taken 
to wet 4 cm of the membrane.) 
Sl no Manufacturer Description Capillary rise 
sec/4 cm 
Thickness 
 (μm) 
Backed 
1 Whatman 
membranes 
AE 98 160--210 120 No 
2 Whatman 
membranes 
AE 99 120--160 120 No 
3 Whatman 
membranes 
FF 125 100--150 200 Mylar 
4 Pall Corporation VIVID170LFNC 150-225 200 Polystyrene 
 
The first two membranes are unbacked with just the nitrocellulose membrane. The last two are 
backed membranes which are backed with Mylar and polystyrene respectively. Unbacked 
membranes are typically used in preliminary work where the concentration of the antibodies, pH 
and the amount of target needs to be optimized. They are difficult to handle owing to their brittle 
nature as compared to backed membranes which offer greater robustness. The lateral flow strips 
were made by assembling the nitrocellulose membrane, the glass fiber sample pad (FUSION 5, 
Whatman GE Healthcare), and the absorbent pad (CF5, Whatman GE Healthcare) on a 
polystyrene adhesive backing strip (G&L Precision Die Cutting, LLC).    
To detect the labeled amplified PCR or LAMP product the nitrocellulose membrane is 
striped across its width with Anti-FITC (for E. coli malB)  or Anti-Dig antibody (for E. coli STX-
1 and K. pneumoniae) (Sigma Aldrich) of concentration 1 mg/mL in the striping buffer (PBS, pH 
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7.4), which constitutes the test line and Anti-streptavidin IgG (Sigma Aldrich) of concentration 1 
mg/mL in the striping buffer which constitutes the control line. Approximately, 1000 ng of Anti-
FITC/Anti-Dig antibody and 720 ng of Anti-streptavidin were dispensed using an airbrush (Iwata 
HP-A Plus) and the lines were striped at a distance of 30 mm apart from each other. The strips 
were dried at room temperature for 1 hour before use and were stored in air-tight containers at 
room temperature. 
 
Detection procedure 
 The colloidal gold nanoparticles (GNPs) conjugated with streptavidin purchased from Bioassay 
Works® have a mean diameter of 40 nm and a concentration of 15 OD.  About 10 μL of the PCR 
product was added to 10 μL of the GNPs in 200 μL of the flow buffer. This was then applied to 
the sample pad of the lateral flow strip and was allowed to develop for 25 minutes. The strip was 
again washed with the flow buffer to remove any GNPs which were bound to the membrane non-
specifically.   
 
Effect of pH 
Three different buffers were used, namely HEPES (pH 6.3), PBS (pH 7.3) and Tris-HCl (pH 8.8) 
as the flow buffers for the lateral flow assay. At higher pH, when the Tris-HCl buffer was used 
as the flow buffer, the binding was almost non-existent. We found that the HEPES buffer which 
consists of HEPES (10 mmol), NaCl (135 mmol), BSA (2%) and Tween 20 (0.05%) performed 
best for our assay (results not shown) as was used as the lateral flow buffer for all future 
experiments.  
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3.3.3 Detection of PCR product on lateral flow strips 
The forward primer and reverse primers for E. coli malB were labeled with FITC and 
biotin respectively. For both E. coli STX-1 and K. pneumoniae, the forward primer and reverse 
primers were labeled with Digoxigenin and biotin respectively. These forward and reverse 
primers were used as the outer primers (F3 and B3) for LAMP as will be seen later. Table 6 
shows the sequence of the primers used and Figure 9 shows their location on the genome.  
 
Table 6.  PCR primers for E. coli malB, E. coli STX-1 and K. pneumoniae. 
Organism Primer name 
 
Primer Sequence 
E. coli malB F3 5’-FITC-ATTTACCGCAGCCAGACG -3 
E. coli malB B3 5’-Bio-GCCATCTCCTGATGACGC-3’ 
E. coli STX-1 F3 5’-Dig-ACAGAGGGGATTTCGTAC-3’ 
E. coli STX-1 B3 5’-Bio-GATGACAATTCAGTATTAATGC-3’ 
K. pneumoniae F3 5’-Dig-AAACTGATTGGTCTGCCGG-3’ 
K. pneumoniae B3 5’-Bio-TGCATCCCTATCTTTTTACC-3’ 
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 E. coli malB gene (GDB J01648) 
1 GAAACACCAT ACCAACGCCA CGTTCTGCTG GCGGAGTGTC ATTCATCCGT TTCTCACCGA 
 
61    TGAACAGGTC GCCGCTGGTG ATCGTCTCAA GCCCGGCAAT CATGCGCAGT AAAGTCGATT 
      F3 
121   TACCGCAGCC AGACGGTCCG ACAAACACCA CGAATTCACC TTCATGGATA TCGAGATTGA 
 
181   TATCTTTCGA TACCACGACC TCGCCCCAGG CTTTCGTTAC ATTTTGCAGC TGTACGCTCG 
 
241   CCATGCCCTT CTCCCTTTGT AACAACCTGT CATCGACAGC AACATTCATG ATGGGCTGAC 
 
 
301   TATGCGTCAT CAGGAGATGG CTTAAATCCT CCACCCCCTA GCTTTTTTAT GGGGGAGGAG 
                     B3 
 
E. coli STX-1 gene (GDB: AM230663.1) 
                 F3 
1 TTTTCGGCAA ATACAGAGGG GATTTCGTAC AACACTGGAT GATCTCAGTG GGCGTTCTTA  
61    TGTAATGACT GCTGAAGATG TTGATCTTAC ATTGAACTGG GGAAGGTTGA GTAGTGTCCT  
121   GCCTGATTAT CATGGACAAG A-CTCTGTTC GTGTAGGAAG AATTTCTTTT GGAAGCATTA  
181   ATGCAATTCT GGGAAGCGTG GCATTAATAC TGAATTGTCA TCATCATGCA TCGCGAGTTG  
241   CCAGAATGGC                       B3 
 
  
K. pneumoniae (GDB AF411142) 
1     GGGACCCTCG CCTCCGGCGC GCTGCTGGCG GTACTGCTGT ATATGATGGG GATGCTCGGC 
                        F3                                
61    CACAAACTGA TTGGTCTGCC GGCGCCGGTA GGCATGCTGT TCCTCGCGGT ACTGTTAAAG 
 
121   CTGGCTAACG TGGTGTCTCC GCGTCTGCAG GAGGGGTCGC AGATGGTGTA TAAATTCTTC 
                                                            
181   CGCACCGCGG TCACCTACCC GATCCTCTTT GCCGTCGGCG TGGCGATCAC TCCGTGGCAG 
                                           B3    
241   GAACTGGTAA ACGCCTTCAC TTTAACCAAC CTGCTGGTGA TCGTCAGTAC CGTCTCCGCG 
 
Figure 9. Location of the PCR primers on the E. coli malB (GDB J01648), E. coli STX-1 
(GDB AM230663.1) and K. pneumoniae (GDB AF411142) gene respectively.   
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PCR reaction 
The PCR reaction mixture (total 25 μL) contains 1 μL each of the labeled forward and reverse 
primers (concentration 10 μM), 0.8 μL of Taq DNA polymerase, Thermopol reaction buffer (1X) 
which contains 20 mM Tris –HCl (pH 8.8, @ 25ºC), 10 mM KCl , 10 mM (NH2)SO4, 2 mM 
MgSO4, 0.1% Triton X-100 (New England Biolabs Inc., MA, USA) and 2 μL of 1.25 mM 
dNTP. The PCR reaction was conducted in a BioRAD PCR thermocycler with 40 or 15 
temperature cycles of 95 oC for 30 seconds, 57 oC for 30 seconds and 72 oC for 90 seconds. 
 
Detection of PCR products on agarose gel 
The PCR amplified E. coli malB, E. coli STX-1 and K. pneumoniae were detected in a 2% 
agarose gel with Sybr DNA staining dye with UV illumination along with the negative target 
control (NTC). Comparison with the ladder shows (Figure 10) that the band for the PCR 
amplified E. coli malB corresponds to 195  bases, E. coli STX-1 to 210 bases and K. pneumoniae 
corresponds to 222 bases which is the region between the forward primer F3 and the reverse 
primer B3.   
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Figure 10. Gel image of K. pneumoniae, E. coli STX-1 and E. coli malB,  amplified by 
PCR for a) 40 cycles and b) 15 cycles with the negative target control (NTC) on the left followed 
by the band indicating positive amplification and the ladder (M). The 100kb ladder shows that 
the amplified product is about 200 bps long. For the 40 temperature cycles, the formation of 
primer dimer is visible (shown in the black circles) whereas for 15 cycles, no primer dimer 
seems to be present. The target used for PCR was the K. pneumoniae clone, E. coli STX-1 DNA 
extracted from urine samples and E. coli malB clone. As the copy number of the clone is very 
high (of the order of 106 copies/µL), even at 15 cycles there is a strong positive band for K. 
pneumoniae and E. coli malB, whereas for the extracted E. coli STX-1 DNA, it is only faintly 
visible.   
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Detection on lateral flow strips 
Shown in Figure 11 is the detection of E. coli malB after 40 cycles with its negative target 
control (NTC) on all four lateral flow membranes mentioned before. As can be seen, the NTC 
also shows a faint binding which is due to the formation of primer-dimer. In PCR the primary 
interaction is between the primers and the template/target which gives rise to specific 
amplification. However, as the concentration of the forward and reverse primers is high, weak 
primer interaction with each other cause the formation of non-specific dsDNA products which 
reduce the amplification efficiency. Studies have shown that even no base complementarity at 
the 3` end causes a primer dimer to be formed after 40 cycles 104. Although this has an effect on 
the efficiency of the amplification, in most cases it is not deleterious to the performance of PCR. 
When labeled PCR products are run over a nitrocellulose membrane in a lateral flow strip, the 
only labels that need to be detected are the labels on the specifically amplified product. So, when 
two labeled primers form dimers, it leads to the formation of a short dsDNA product which is 
non-specific, but one which contains both labels. This labeled non-specific product acts as the 
labeled specifically amplified product and produces a false positive as seen in Figure 11.    The 
formation of primer dimers can be reduced by careful primer design, reduction in the number of 
cycles for amplification, hot start PCR, touch-down PCR and other methods. When PCR for E. 
coli malB was carried out for 15 cycles, there is no primer dimer seen in the gel and there is no 
false positive as seen in Figure 12. The backed membranes namely VIVID170, Pall and FF125, 
Whatman had better sensitivity and contrast between the positive and the negative samples when 
compared to the unbacked membranes. FF125 was chosen to be the membrane as it had excellent 
flow properties and high sensitivity and was used thereafter. Figure 13 shows the detection of E. 
coli STX-1 and K. pneumoniae amplified by PCR for 15 cycles on lateral flow strips assembled 
with FF125 membranes. Here the test line was Anti-Dig antibody as previously mentioned.    
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To validate the formation of primer-dimer, real time PCR was performed in an Applied 
Biosystems 7900HT Real time PCR machine with 1 µL Sybr Green dye added to detect the real 
time fluorescence. Sybr Green is a DNA intercalating dye which binds specifically to dsDNA. 
So, if there is target present, the intensity of the fluorescence increases as the dsDNA is being 
synthesized.   PCR was conducted with one positive control, where the E. coli malB clone was 
added to the reaction as the target and one NTC where de-ionized water was added as the target. 
The primers used were the forward and reverse primers (F3 and B3) for E. coli malB whose 
sequences are given in Table 6. After 40 temperature cycles of PCR at 95 oC for 30 sec, 57 oC 
for 30 sec and 72 oC for 1 min, the temperature is brought to 60 oC where it is maintained for 1 
minute. The temperature is ramped up slowly at a rate of 2 oC/ min and the real time 
fluorescence intensity is recorded. At a particular temperature, the dsDNA products dissociate 
and this temperature is a function of the length of the dsDNA. If there is any primer dimer 
present, the temperature at which the dimers dissociate would be lesser than the specifically 
amplified positive control. The dissociation curve plots the derivative of the fluorescence 
intensity change versus temperature which gives information about the dissociation temperature 
of the primer-dimer (from the NTC), if present, and the amplified product. From Figure 14 it can 
be observed that for the positive control PCR reaction, the dissociation temperature  is around 84 
oC and for the NTC it is around 73 oC. The primers would therefore have to be redesigned or the 
number of cycles has to be reduced to around 15 which would have a negative effect on the 
sensitivity.  
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Figure 11. Detection of PCR amplified E. coli malB DNA labeled with FITC and biotin 
after 40 cycles along with their NTCs (denoted by the ‘-‘ sign on the figure) on lateral flow strips 
assembled with different nitrocellulose membranes a) VIVID170LFNC, Pall Corp b) FF125, 
Whatman c) AE99, Whatman d) AE98, Whatman.   
 
 
 
Figure 12. Detection of PCR amplified E. coli malB DNA labeled with FITC and biotin 
after 15 cycles along with their NTCs (denoted by the ‘-‘ sign on the figure) on lateral flow strips 
assembled with different nitrocellulose membranes a) VIVID170LFNC, Pall Corp b) FF125, 
Whatman c) AE99, Whatman d) AE98, Whatman.   
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Figure 13. Detection of PCR amplified a) E. coli STX-1 and b) K. pneumoniae DNA 
labeled with Dig and biotin after 15 cycles along with their NTCs (denoted by the ‘-‘ sign on the 
figure) on lateral flow strips assembled with FF125, Whatman.  
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Figure 14. Dissociation curve for E. coli malB amplification products after PCR for 40 
cycles in a real time PCR machine. a) NTC b) Specifically amplified E. coli malB positive 
control 
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 The primers for PCR were redesigned for E. coli malB by extending them to cover a 
region of 308 bps (See the location of F3 and B3 in Figure 17) and was checked again with real 
time PCR to see if any dimers were formed. Shown in Figure 15 is the dissociation curve for the 
newly designed PCR primers which are compared alongside the old primers. As can be seen, 
there is no formation of primer dimer and this can now be used to amplify the E. coli target with 
40 temperature cycles and then run on a lateral flow strip without encountering a false positive 
for the NTC.     
 
Figure 15. Dissociation curve for E. coli malB amplification products after PCR for 40 
cycles in a real time PCR machine. a) NTC with old primers b) NTC with the extended primers 
c) Specifically amplified E. coli malB positive control 
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3.3.4 LAMP primer design 
Nucleic acid amplification is the cornerstone for detection of genetic variation, infectious 
diseases and harmful mutations. PCR is the most widely used nucleic acid amplification 
technique, but recently other DNA amplification techniques such as NASBA (nucleic acid 
sequence based amplification), self-sustained sequence replication (3RS) and strand 
displacement amplification (SDA). Each of these above mentioned methods utilize a different 
technique to reinitiate the DNA replication process from the previous round. PCR utilizes heat 
denaturation, NASBA and 3RS utilize a set of transcription and reverse transcription to amplify 
and SDA and LAMP utilize the polymerase’s strand displacement activity to amplify without 
heat denaturation of the DNA strands.  
Although PCR thermal cyclers are expensive and require skilled personnel to work it, 
they are still the most reliable nucleic acid amplification technique available today. This is due to 
the fact that the other methods barring LAMP suffer from low specificity and residual 
coamplification of unwanted sequences which increase background noise. LAMP as first 
described by Notomi et al 89 is isothermal and relies on the heavy strand displacement activity of 
the Bst DNA polymerase enzyme. It can be carried out with 4 primers namely F3, B3 (outer 
primers) and FIP and BIP (inner primers).  The addition of loop primers has been shown to 
accelerate the reaction 90 such that the total time required for amplification is about half the 
original time when only 4 primers are used. In the initial steps all four primers are used, but 
during the later stages, only the inner primers are used. Shown below in Figure 16 is the location 
of the six distinct regions which are recognized by the LAMP primers: 
 
 61 
 
 
Figure 16. LAMP primers and their location on the target DNA. 
 
The mechanism of LAMP amplification can be described in the following steps: 
1. First, the F2 portion of FIP (F1c+F2) binds to the F2c region on the target DNA and 
completes the strand.  
2. F3 binds to the F3c region and start to build the complementary strand while displacing 
the DNA strand formed by FIP with the help of the strand displacing Bst polymerase. 
Now, the displaced strand contains F1c, the region from the FIP primer which was 
unused in the building of the complementary strand and F1 which was synthesized. When 
this single strand DNA is broken off, a loop is formed by the binding of F1 and F1c.     
3.  The region B2 ( B1c+B2) of BIP binds to the B2c region of this displaced ssDNA strand 
which contains the loop and the complementary strand is synthesized while opening out 
the loop formed between F1 and F1c. 
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4. B3 now binds to the B3c region and starts to build the complementary strand while 
displacing the DNA strand formed by BIP with the help of the strand displacing Bst 
polymerase. This gives rise to a ssDNA strand with two loops: One formed between F1 
and F1c and the other formed between B1 and B1c.  
This serves as the starting material for LAMP amplification. 
5. F2 of FIP (F1c+F2) now binds to the loop and DNA is synthesized. Thus, with a single 
strand DNA template, two identical strands complementary to the starting structure are 
synthesized. As the F1 portion of the loop elongates, it displaces the loop formed by the 
B1 + B1c. The new strand created by the F1 portion of the loop also contains B1c + B1 
which forms a loop. With the newly synthesized strand by the F1 portion of the loop as 
the template, the loop continues to build displacing the F1c portion of the primer which 
started step 5 and also the strand which was synthesized by it. This strand displaced is 
again the starting material for LAMP.  
6. The single looped (B1+B1c) dsDNA structure left behind now has BIP bind to it and 
carry out the building of the complementary strand. As the new complementary strand is 
being synthesized, the other strand which was complementary to the target before BIP 
binds to it gets displaced. This structure now has 3 loops. Simultaneously, the starting 
material which was formed in step 5 also has BIP bind to it and build its complementary 
strand.      
7. The process continues and during amplification, a series of products are formed which 
are multiples of the region marked by F3 and B3. Thus when these amplification products 
are run in a gel, they give rise to a ladder like pattern instead of a single band as in PCR.  
The LAMP primers for E. coli malB, E. coli STX-1 and K. pneumoniae were designed using 
Primer Explorer Primer Explorer V3 software provided by Eiken Chemical Co., Ltd, which can 
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be found here: http://loopamp.eiken.co.jp/e/lamp/primer.html. The primer sequences are given in 
Table 7 and their location on their  respective genome is as shown in Figure 17.  
 
Table 7. LAMP primer sequences  
E. coli malB gene 
Primer Sequence Bases 
F3 5’-CTGGTGATCGTCTCAAGCCCGGC-3’ 23 
B3 5’-GCCGCGTTCTCATCCTCCCG-3’ 20 
FIP (F1C+F2) 5’-CTGGGGCGAGGTCGTGGTAT-TCCGACAAACACCACGAATT -3’ 42 
BIP (B1c+B2) 5’-CATTTTGCAGCTGTACGCTCGC-AGCCCATCATGAATGTTGCT-3’ 44 
Loop F 5’-FITC- ATCAATCTCGATATCCATGAAGGTG-3’ 25 
Loop B 5’-Biotin-CTTTGTAACAACCTGTCATCGACA-3’  24 
 
E. coli STX-1 gene 
Primer Sequence Bases 
F3   5’- ACAGAGGGGATTTCGTAC-3’ 18 
B3 5’- GATGACAATTCAGTATTAATGC-3’ 22 
FIP (F1c+F2) 5’-CCTTCCCCAGTTCAATGTAAG-CTGGATGATCTCAGTGGGC-3’ 40 
BIP (B1+B2c) 5’-GTCCATGATAATCAGGCAGG-GCATTAATGCAATTCTGGGAAG-3’ 42 
Loop F 5’- Dig-CATCTTCAGCAGTCATTAC-3’ 19 
Loop B 5’-Bio-CTGTTCGTGTAGGAAGAATTTC-3’ 22 
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K. pneumoniae citw gene 
Primer Sequence Bases 
F3   5’-AAACTGATTGGTCTGCCGG-3’ 19 
B3 5’-GACGATCACCAGCAGGTTG-3’ 19 
FIP (F1c+F2) 5’-TACACCATCTGCGACCCCTC CTGTTCCTCGCGGTACTGT -3’ 39 
BIP (B1+B2c) 5’-GGCAAAGAGGATCGGGTAGGTGGGAACTGGTAA ACGCCTTCA-3’ 
 
42 
Loop F 5’-Dig-ACACCACGTTAGCCAGCTT-3’ 19 
Loop B 5’-Biotin-CGTGGCGATCACTCCGT -3’ 17 
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E. coli malB gene (GDB J01648) 
 
1 GAAACACCAT ACCAACGCCA CGTTCTGCTG GCGGAGTGTC ATTCATCCGT TTCTCACCGA 
                        F3  
61    TGAACAGGTC GCCGCTGGTG ATCGTCTCAA GCCCGGCAAT CATGCGCAGT AAAGTCGATT     
                          F2                        LF 
121   TACCGCAGCC AGACGGTCCG ACAAACACCA CGAATT*CACC TTCATGGATA TCGAGATTGA  
                     F1c                 B1c 
181   TATCTTTCGA TACCACGACC TCGCCCCAGG CTTTCGTTAC ATTTTGCAGC TGTACGCTCG 
 
                             LB                B2 
241   CCATGCCCTT CTCCCTTTGT AACAACCTGT CATCGAC|A|GC AACATTCATG ATGGGCTGAC 
 
 
301   TATGCGTCAT CAGGAGATGG CTTAAATCCT CCACCCCCTA GCTTTTTTAT GGGGGAGGAG 
 
 
361   GCGGGAGGAT GAGAACGCGG CTTCTGTGA  389                B3 
 
 
 
E. coli STX-1 (GDB AM230663.1) 
 
                 F3                         F2 
1 TTTTCGGCAA ATACAGAGGG GATTTCGTAC AACACTGGAT GATCTCAGTG GGCGTTCTTA 
           
           LF                  F1c 
61    TGTAATGACT GCTGAAGATG TTGATCTTAC ATTGAACTGG GGAAGGTTGA GTAGTGTCCT  
 
            B1                   LB                 
121   GCCTGATTAT CATGGACAAG A-CTCTGTTC GTGTAGGAAG AATTTCTTTT GGAAGCATTA 
 
      B2c 
181   ATGCAATTCT GGGAAGCGTG GCATTAATAC TGAATTGTCA TCATCATGCA TCGCGAGTTG  
                                  B3 
241   CCAGAATGGC    
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K. pneumoniae citw (GDB AF411142) 
 
1     GGGACCCTCG CCTCCGGCGC GCTGCTGGCG GTACTGCTGT ATATGATGGG GATGCTCGGC 
                     F3                               F2   
61    CACAAACTGA TTGGTCTGCC GGCGCCGGTA GGCATGCTGT TCCTCGCGGT ACTGTTAAAG 
 
          LF                           F1c 
121   CTGGCTAACG TGGTGTCTCC GCGTCTGCAG GAGGGGTCGC AGATGGTGTA TAAATTCTTC 
                                                            
                       B1                  LB  
181   CGCACCGCGG TCACCTACCC GATCCTCTTT GCCGTCGGCG TGGCGATCAC TCCGTGGCAG 
                  B2C                       B3    
241   GAACTGGTAA ACGCCTTCAC TTTAACCAAC CTGCTGGTGA TCGTCAGTAC CGTCTCCGCG 
 
Figure 17. Location of the six LAMP primers, namely the outer primers (F3 and B3) , 
the inner primers (FIP and BIP) and the labeled loop primers (LF and LB) on the E. coli malB 
(GDB J01648), E. coli STX-1 (GDB AM230663.1) and Klebsiella Pneumoniae citw gene (GDB 
AF411142) respectively.  The forward inner primer (FIP) consists of F1c+ F2 and the backward 
inner primer consists of B1+B2c. The reverse complimentary sequences of the primers are 
italicized. For E. coli malB, Loop B and B2 overlap by one base which is depicted between two 
vertical lines “| A|” and Loop F and F2 are contiguous which  are separated by a “*” symbol for 
ease of reading. The outer primers for E. coli malB are the extended primers which did not form 
primer dimers in PCR.      
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LAMP reaction 
The LAMP reaction was carried out in  a total reaction volume of 25 µL that contained the three 
primer pairs in the ratio 1:4:8, i.e. 0.2µM each of outer primers (F3 and B3), 0.8µM each of loop 
primers (LF and LB) and 1.6µM each of inner primers (FIP and BIP) respectively for each 
organism. For the multiplex reactions, the primers for both E. coli malB and K. pneumoniae or E. 
coli malB and E. coli STX-1 were mixed in the ratio 1:1 and their individual concentrations were 
unchanged in the reaction mixture. The other components of the reaction mix were: 2.5 µL of 
10X Bst DNA polymerase reaction buffer; 1 µL of 8 U/µL Bst DNA polymerase (New England 
Biolabs Inc., MA, USA), 2 µL of 100 mM of MgSO4, 5 µL of Betaine (Sigma Aldrich, MO, 
USA), 2.5 µL deionized water and 2.5 µL of target sample. The Bst DNA polymerase reaction 
buffer (1X) contained 20mM Tris –HCl (pH 8.8, @ 25ºC), 10mM KCl , 10mM (NH2)SO4, 2mM 
MgSO4, 0.1% Triton X-100(New England Biolabs Inc., MA, USA). The LAMP reaction was 
primarily carried out in a heating block (LAB-LINE, Barnstead International, Dubuque, Iowa, 
USA). The negative target control (NTC) for LAMP contained all the reagents in the reaction 
mixture  and water (for the target). The LAMP amplification products are detected by several 
methods, including gel electrophoresis and on lateral flow strips. Shown in Figure 18 is the 
detection of LAMP product in a 2% agarose gel with the aid of Sybr DNA staining dye and UV-
transillumination. 
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Figure 18. Gel image showing the positive LAMP reaction and its negative target control 
(NTC) for a) E. coli malB b) E. coli STX-1 c) K. pneumoniae  
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3.3.4.1 LAMP with labeled primers 
 
As with carrying out PCR with labeled primers, the factors that need to be considered when 
performing LAMP with labeled primers are that the reaction should remain unaffected by the 
presence of the labels and that there are sufficient labels to enable a sensitive detection on lateral 
flow strips. As with PCR the primer-dimer formation during the LAMP reaction needs to be 
minimized. With six primers present in the reaction mixture, it is a daunting task to prevent the 
formation of primer-dimers between each of the primers. Also, the length of the inner primers is 
around 40 nucleotides long which make it difficult to prevent dimers. But, as long as the 
efficiency of the reaction remains largely unaffected, the dimer formation between the unlabeled 
primers does not interfere with the detection scheme on the lateral flow strips. It is the dimer 
formation with the labeled primers which needs to be prevented to eliminate the possibility of a 
false positive. As LAMP utilizes six primers for amplification, we have the following choices of 
labeling the primers: 
1. Outer primers: The outer primers F3 and B3 can be labeled with FITC and biotin 
or Dig and biotin. 
2. Inner primers: FIP and BIP could be labeled  
3. Loop primers: LF and LB could be labeled  
4. One of the inner primers + a labeled ssDNA probe 
 
Each of these label choices were first tested for E. coli malB and the most optimum choice was 
applied to E. coli STX-1 and K. pneumoniae.   
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1. Outer primers:  
As the E. coli malB F3 and B3 formed primer dimers when used as the forward and reverse 
primers in PCR, they were redesigned by extending them on the E. coli genome. Their location is 
as shown in Figure 17. From Figure 15, it was established earlier that the newly designed 
extended outer primers do not form a primer dimer as indicated by the flat dissociation curve for 
the negative target control (NTC). Although the labeled F3 and B3 do not form dimers, the 
sensitivity of the detection on lateral flow strips after LAMP was found to be poor. When a target 
which has a copy number of around 106 copies/µL was used, a clear distinction between the 
positive and negative strip can be made (Figure 19). When dealing with clinical samples, a 
target concentration of 102 copies/ µL or lesser should be easily detected on the lateral flow strip.  
But when the target concentration is reduced to below the 106 copies/µL limit, the detection on 
the lateral flow strips becomes inconsistent and therefore unreliable (results not shown). This is 
primarily because the concentration of the labeled outer primers F3 and B3 in the LAMP 
reaction is only about 77 nM each. When these are used as the forward and reverse primers in 
PCR, their concentration is 500 nM in the same reaction volume. Therefore, the choice of 
labeling the outer primers was disregarded due to poor sensitivity and visual contrast when the 
target DNA concentration is in the clinically relevant range.     
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Figure 19. A positive reaction along with its NTC detected on lateral flow strips using 
labeled outer primers for amplification by LAMP. The concentration of the target is ~3.16 x 106 
copies/µL as determined by UV spectroscopy at 260 nm. 
  
2. Inner primers: 
The labeling of the inner primers FIP with FITC and BIP with biotin for E. coli malB reduced 
the efficiency and even made the amplification process unreliable. So, although the FIP and BIP 
primers are present in a large quantity in the reaction mixture, they were not ideal for labeling.  
 
3. Inner primer + ssDNA probe: 
In previous studies,  a labeled BIP primer has been used in conjunction with a labeled ssDNA 
probe93-95 to form the sandwich structure required for detection by lateral flow. This ssDNA 
probe was added to the reaction mixture after the LAMP reaction was completed and allowed to 
hybridize with the amplified double stranded DNA with the aid of the strand displacing Bst 
enzyme. This would entail opening of the reaction tube which could possibly lead to 
contamination of the reaction and of the surroundings by the amplified product. LAMP amplifies 
with high efficiency with over 106 copies in less than an hour. Aerosol from the amplified 
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product could contaminate the surroundings.  Hence this scheme, although successful, was 
disregarded.   
 
4. Labeled loop primers: 
The loop primers are present in sufficient quantity and when labeled do not interfere with the 
efficiency of the LAMP reaction. Hence they are ideally suited for labeling for detection by 
lateral flow. As before, the possibility of formation of primer dimers was checked by using real 
time PCR. Shown in Figure 20 are the following dissociation curves: the positive control for the 
reaction (d) and the loop primers added to the PCR reaction without any target for E. coli malB 
(a), E. coli STX-1 (b) and K. pneumoniae (c) LAMP primers. As seen from the figure, the 
dissociation curve is flat for the reactions with just the loop primers for the respective organisms 
showing no presence of primer dimer. A peak at around 81 oC is seen for the positive control 
which is representative of the amplified product. Hence the loop primers were chosen to be 
labeled as they are sensitive, and give rise to no false positives.  
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Figure 20. Dissociation curve to check for the presence of primer dimers for the loop 
primers of a) E. coli malB b) E. coli STX-1 and c) K. pneumoniae along with a d) positive 
control  
 
After the labeled primers, antibody concentrations, nitrocellulose membranes and the pH 
of the lateral flow buffer have been optimized, the sensitivity of the lateral flow strip detection 
scheme can be further improved by striping the test line and control line antibodies on the 
nitrocellulose membrane on a narrow line at a high concentration. This is difficult to achieve 
with a micropipette or an air brush. In large scale lateral flow strip manufacture, the antibodies 
are typically sprayed on to the nitrocellulose membrane using lateral flow reagent dispensers 
which dispense a very fine spray of concentrated antibody solution ensuring the thickness of the 
test and control line does not exceed 2 mm. Commercially available lateral flow strips, BESt 
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Type II cassettes (Biohelix Corp, MA, USA) were used to detect the E. coli malB, E. coli STX-1 
and K. pneumoniae LAMP products. The BESt type II contains dried colloidal gold 
nanoparticles (GNPs) conjugated with Anti-Biotin antibody on the conjugate pad and Anti-FITC 
and Anti-Digoxigenin antibodies striped across the membrane to serve as the test (T) and control 
(C) lines respectively. The Anti-Digoxigenin immobilized as the control line is actually meant to 
detect a second set of DNA amplicons labeled with Biotin and Digoxigenin, which in our case is 
the E. coli STX-1 and K. pneumoniae. After amplification by LAMP, about 10 μL of the product 
was used as sample for the BESt Type II cassettes and allowed to develop for 5 minutes. Figure 
21 shows the detection of E. coli malB, E. coli STX-1 and K. pneumoniae on lateral flow strips 
along with their negative target controls.   
 
 
 Figure 21. Detection of a) E. coli malB (E), b) E. coli STX-1 (ST) and c) K. pneumoniae 
on lateral flow strips along with their NTCs.  
 
Specificity of the primers of the LAMP reaction  
The specificity of the E. coli malB, E. coli STX-1and K. pneumoniae primers was checked by 
performing the LAMP assay for various bacteria namely Haemophilus influenzae (H), 
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Streptococcus pyogenes (SP), Streptococcus viridans (SV), Corynebacterium diptheriae (C), 
Nisseria gonorrhea (G), Lactobacillus Iners (L), Staphylococcus epidermis (SE),  Klebsiella 
pneumoniae (K), Escherichia coli malB (E) and E. coli STX-1 (ST). The LAMP products were 
seen only when the E. coli malB, E. coli STX-1 or the   K. pneumoniae DNA was present in the 
assay with the matched primer set and was negative for other organisms tested (Figure 22). The 
E. coli STX-1 DNA was extracted from urine samples which also contains the E. coli malB gene. 
Hence, when E. coli malB is used as the target with the E. coli STX-1 primers, there is a ladder 
showing amplification.  
 
 
Figure 22. Specificity of the LAMP primers for a) E. coli malB, b) K. pneumoniae and c) 
E. coli STX-1  
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Sensitivity of the LAMP/Lateral flow detection scheme 
The sensitivity of the LAMP/lateral flow detection was evaluated only for E. coli malB 
assay by using a set of serial dilutions of cloned PCR amplicon as the target. The E. coli malB  
clone was prepared by using StrataClone PCR cloning kit (Stratagene, La Jolla, CA, USA) by 
incorporating E. coli malB PCR product (307 bps) into the plasmid (~4.3 kbps). The E. coli PCR 
product was prepared by amplifying the   genomic DNA with the outer primers F3 and B3 as the 
forward and reverse primer respectively. The concentration of the E. coli malB clone was 
determined by UV spectrophotometry (BIO-RAD Smartspec 3000) at 260 nm to be ~3.14x1010 
copies/µL. 
A total of eleven ten-fold serial dilutions of the clone were made, containing ~3 
x1010copies/µL in 1st dilution  to 3 copies/µL in 10th  dilution.  11th dilution had less than 3 
copies / µL.  A volume of 2.5 µL of each of the dilutions was added as target to the LAMP 
reaction along with a negative target control. A clear ladder pattern is seen for dilutions 1-10 
with the intensity of the bands decreasing from dilution #7 (Figure 23a).  Thus, the sensitivity 
for an E. coli malB LAMP reaction was determined to be 8 copies/ reaction. Similar results were 
obtained when the LAMP reaction was performed in an Applied Biosystems 7900HT Real time 
PCR machine using the 3rd dilution to the 10th dilution as targets (Figure 23b). Shown in Figure 
23c is the detection of the LAMP amplified product on lateral flow strips for the 8th dilution 
(~8x102 copies) to the 11th dilution (<3 copies) along with the NTC. The lateral flow strips 
display excellent sensitivity and are readily able to detect the 10th dilution which contained ~8 
copies as the target for LAMP.   
A plot of the time taken to cross the threshold value of fluorescence versus the copy 
number of the E. coli malB clone added as target (Figure 23d) shows that when the copy number 
of the target increases logarithmically, the time taken to reach the threshold fluorescence 
decreases linearly. Both E. coli and K. pneumoniae are commonly present in the large intestines 
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of mammals and an infection is said to have occurred only when the concentration as determined 
by bacterial culture is greater than 100,000 CFUs/mL of urine. Collection of urine samples from 
suspected UTI patients is done in a sterile manner so as to avoid contamination of the urine with 
fecal matter which contains E. coli. Even in the worst cases of contamination during collection, 
the number of cells in CFUs/mL of urine as determined by bacterial culture should not exceed 
this upper threshold value. Quantification is therefore imperative so as to prevent detection of 
false positives.  Detection by LAMP which has sensitivity of the order of tens of copies could be 
deemed too sensitive to be used as a reliable quantitative diagnostic tool, but this apparent 
weakness could be overcome by reducing the duration of amplification so as to detect only those 
samples with sufficiently high concentration of pathogenic DNA.   By reducing the time required 
for amplification, only those samples with a minimum copy number can be amplified thereby 
enabling us to set a threshold limit on the copy number which makes it very useful in the clinical 
setting. If the threshold value for the copy number of E. coli is set as 102 copies/µL then, 
performing the LAMP reaction for 50 minutes (Figure 23d), amplifies only those targets with 
copy number greater than this set threshold.  
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Figure 23. Sensitivity of the LAMP-Lateral flow detection scheme. a) Gel image of 
LAMP reaction performed with serial dilutions of E. coli malB clone as target. Lane 1 
corresponds to the 1st dilution and lane 11 the 11th dilution. Lane 10 contained ~8 copies which 
sets the limit for sensitivity. The NTC contains no E. coli malB clone. b) Real time amplification 
curves when serial dilutions of E. coli  malB (Dilutions 3-10) were added as target for LAMP. 
After the 10th dilution, no amplification was seen. The horizontal green line is fixed as the 
threshold value of fluorescence.   c)  Detection of 8th to 11th dilution along with the NTC on a 
commercially available lateral flow strip (BESt Type II cassettes, Biohelix Corp, MA, USA). 
Dilution 11 and the NTC show no positive test line as expected.  d) Plot of time taken to reach 
the threshold value of fluorescence versus log(copy number). The time required for amplification 
to detect 10 and 100 copies is shown by the blue and green dotted lines respectively.   
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3.3.4.2 Multiplexing detection 
 
Although an E. coli and K. pneumoniae infection rarely occurs simultaneously, it is nevertheless 
advantageous to multiplex their detection. Multiplexing saves time, cost of detection and would 
be very helpful in administering rapid and accurate treatment to UTI patients. Here, multiplexing 
relies on sensitive and specific amplification of the target organism’s DNA and its subsequent 
detection on lateral flow strips. Two cases of multiplexing are presented here: The first being the 
detection of E. coli  and K. pneumoniae, the two most commonly occurring bacteria in UTIs and 
the second case being the detection of the E. coli malB and E. coli STX-1 genes in a single 
reaction and lateral flow strip. The first case is an example of amplification and detection of 
different bacteria whereas the second case is the further narrowing down of the sub-species of 
the bacteria. To carry out a successful multiplex LAMP amplification, the primers for both 
targets need to be present in sufficient quantity and there must be as little cross interaction as 
possible. In LAMP where there are 6 primers per target, it is obviously very difficult to prevent 
all primer interactions. Fortunately, as long as the labeled primers do not interact with one 
another and the efficiency of the amplification for either target remains unaffected, multiplexing 
can be accomplished in a straight forward manner.  
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Case 1. E. coli malB + K. pneumoniae  
 The primers are mixed in the ratio 1:1 in a total reaction mixture of 25 µL and their individual 
concentrations are unchanged i.e. the concentration of E. coli malB primers and the K. 
pneumoniae primers are the same as when the LAMP reaction is carried out individually. The 
loop primers, LF and LB of E. coli malB are labeled with FITC and Biotin and the LF and LB 
primers of K. pneumoniae are labeled with Dig and Biotin as before (Table 7). Earlier, it has 
been established that there is no formation of dimers between the loop primers of E. coli malB 
and K. pneumoniae  when the reactions are performed individually. Now, when multiplexing 
their amplification, we need to consider the formation of dimers between the labeled loop 
primers of the two organisms, namely the dimer formation between LF-FITC of E. coli malB and 
LB-Biotin of K. pneumoniae, LF-Dig of K. pneumoniae and LB-Biotin of E. coli malB and 
finally, when all four loop primers are mixed together. Shown in Figure 24 is the dissociation 
curve when each of the individual cases mentioned above are checked for the formation of 
primer-dimers. As seen in the figure, there is no formation of primer-dimers between any of the 
loop primers of E. coli malB and K. pneumoniae. Shown in Figure 25 is the gel image for the 
detection of E. coli malB and K. pneumoniae for the multiplex reaction and its detection on 
lateral flow strips respectively.   
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Figure 24. Dissociation curve to check for the presence of primer dimer formation 
between a) LF-FITC of E. coli malB and LB-Biotin of K. pneumoniae, b) LF-Dig of K. 
pneumoniae and LB-Biotin of E. coli malB and c) when all four loop primers are added together. 
d) Positive control for the reaction showing the dissociation temperature for amplified dsDNA to 
be around 83 oC.       
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Figure 25. Detection of multiplexed amplification with mixed primers of E. coli malB 
and K. pneumoniae when E. coli malB (E), K. pneumoniae (K) and both  E. coli malB and K. 
pneumoniae (EK) were added as targets in the LAMP reaction on the a) agarose gel b) Lateral 
flow strips 
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Case 2. E. coli malB + E. coli STX-1  
The loop primers, LF and LB of E. coli malB are labeled with FITC and Biotin and the LF and 
LB primers of E. coli STX-1 are labeled with Dig and Biotin as before (Table 7). The ratio of the 
primers in the reaction mixture is 1:1 and their individual concentrations are unchanged. 
As with the E. coli malB + K. pneumoniae, we need to consider the formation of dimers between 
the labeled loop primers of the two genes, namely the dimer formation between LF-FITC of E. 
coli malB and LB-Biotin of E. coli STX-1, LF-Dig of E. coli STX-1  and LB-Biotin of E. coli 
malB and finally, when all four loop primers are mixed together. Shown in Figure 26 is the 
dissociation curve when each of the individual cases mentioned above are checked for the 
formation of primer-dimers. As seen in the figure, there is no formation of primer-dimers 
between any of the loop primers of E. coli malB and E. coli STX-1. The target for the multiplex 
reaction is the DNA extracted from urine samples, which contain both the malB and the STX-1 
genes in the same target dsDNA. Shown in Figure 27 is the gel image for the detection of E. coli 
malB and E. coli STX-1 for the multiplex reaction and its detection on lateral flow strips 
respectively.   
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Figure 26. Dissociation curve to check for the presence of primer dimer formation 
between a) LF-FITC of E. coli malB and LB-Biotin of E. coli STX-1, b) LF-Dig of E. coli STX-1 
and LB-Biotin of E. coli malB and c) when all four loop primers are added together. d) Positive 
control for the reaction showing the dissociation temperature for amplified dsDNA to be around 
80 oC.     
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 Figure 27. Detection of multiplexed amplification with mixed primers of E. coli malB 
and E. coli STX-1 when E. coli malB (E), E. coli STX-1 (St) and both  E. coli malB and E. coli 
STX-1 (ESt) were added as targets in the LAMP reaction on the a) agarose gel b) Lateral flow 
strips.  
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3.3.4.3 Lamp-lateral flow detection of clinical samples  
 
The bacterial strains used in the study were obtained from the microbiology laboratories of the 
Children’s Hospital of Pittsburgh. The urine samples used in this study were residual samples 
that were sent to the microbiology laboratories from patients with suspected UTI and were 
available after all the clinically required studies (i.e. culture and sensitivity) were performed. The 
samples were anonymized by a “honest broker”. These studies were approved as exempt by the 
IRB of University of Pittsburgh. DNA was extracted from bacterial and  urine samples using 
QIAamp DNA Mini-Kit (Qiagen, CA, USA).  
 
96 fresh urine samples from patients with suspected UTI were obtained from the 
microbiology laboratories of Children’s Hospital of Pittsburgh. DNA was extracted from these 
urine samples using QIAamp DNA Mini-Kit (Qiagen, CA, USA) and this was used as the target 
for PCR with the outer primers F3 and B3 as the forward and reverse primers respectively for 
both E. coli malB and K. pneumoniae. As the LAMP reaction performs well in biological 
samples without too much sample preprocessing 91,92, 5 µL of unprocessed urine was used 
directly as target for the LAMP reaction (total 25uL) for both E. coli malB and K. pneumoniae 
and the results were compared to both PCR and bacterial culture results. The reactions were 
performed individually for E. coli malB and K. pneumoniae and also multiplexed by mixing the 
primers in 1:1 ratio as described before. The results from the bacterial culture was taken as 
positive when there are greater than 100,000 CFUs/ml. Out of the 96 urine samples, 9 were 
positive for E. coli malB by bacterial culture, whereas 8 were positive by both PCR with 
extracted DNA and LAMP with direct urine as target using the E. coli malB LAMP primers. 87 
samples were negative for E. coli malB by bacterial culture and 88 were negative for both PCR 
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and LAMP. Furthermore, the 8 samples which were positive by LAMP amplification were also 
positive by the lateral flow assay. For K. pneumoniae, out of the 96 samples, 3 were positive by 
bacterial culture and PCR with extracted DNA and all these were positive by LAMP/lateral flow 
with direct urine as target. The results are summarized in Table 8 and Table 9. The sensitivity 
and specificity of the multiplex reactions for E. coli malB and K. pneumoniae are summarized in 
Table 10. The possible reason for the mismatch of one of the bacterial culture results with PCR 
and LAMP for E. coli malB could be due to excessive degradation of the E. coli DNA in the 
urine sample.      
E. coli STX-1 is typically found in stool and was therefore not screened for in the 96 urine 
samples.  For E. coli STX-1, culture plates which were positive for E. coli STX-1 were used. The 
cells were cultured overnight at 37 oC and then the DNA was extracted from them. PCR was run 
with both the E. coli malB primers and E. coli STX-1 primers. Out of the 20 culture samples, all 
were positive for E. coli malB and 11 were positive for E. coli STX-1 by PCR. LAMP was 
conducted with only the E. coli STX-1 primers (individual reaction) and also multiplexed with E. 
coli malB and E. coli STX-1 primers mixed in the ratio 1:1.  11 out of 11 samples positive by 
PCR and bacterial culture were positive by both LAMP-lateral flow. The results are summarized 
in Table 8 and Table 9. The sensitivity and specificity of the multiplex reactions for E. coli 
malB, K. pneumoniae  and E. coli STX-1 are summarized in Table 10.       
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Table 8. Comparison of LAMP-Lateral flow detection for both E. coli malB and K. 
pneumoniae versus PCR and bacterial culture methods from urine samples with patients 
suspected with UTI. The PCR and LAMP-Lateral flow results for E. coli STX-1 are for extracted 
DNA from culture plates.  
 PCR LAMP-Lateral flow Bacterial culture 
 malB          STX-1 Kleb malB STX-1 Kleb malB STX-1 Kleb 
Number 
positive 
 
8 
 
11 
 
3 
 
8 
 
11 
 
3 
 
9 
 
11 
 
3 
Number 
negative 
 
88 
 
9 
 
93 
 
88 
 
9 
 
93 
 
87 
 
9 
 
93 
 
Table 9. Sensitivity and specificity for LAMP-Lateral flow detection as compared to PCR and 
cell culture methods. 
  
 E. coli malB E. coli STX-1 K. pneumoniae 
Vs PCR Vs Bacterial 
culture 
Vs PCR Vs Bacterial 
culture 
Vs PCR Vs Bacterial 
culture 
Sensitivity 100% 89% 100% 100% 100% 100% 
Specificity 100% 100% 100% 100% 100% 100% 
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  Table 10. Sensitivity and specificity as compared to individual LAMP reactions and 
PCR of E. coli malB, K. pneumoniae and E. coli STX-1 when multiplex primer set is used.  
 
Primer set E. coli malB + K. pneumoniae E. coli malB + E. coli STX-1  
Vs PCR  Vs Individual LAMP reaction Vs Individual LAMP reaction 
Sensitivity for  
E. coli malB 
 
100% 
 
100% 
 
100% 
Specificity for  
E. coli malB 
 
100% 
 
100% 
 
100% 
Sensitivity for  
K. pneumoniae 
 
100% 
 
NA 
 
100% 
Specificity for  
K. pneumoniae 
 
100% 
 
NA 
 
100% 
Sensitivity for  
E. coli STX-1 
 
NA 
 
100% 
 
100% 
Specificity for  
E. coli STX-1 
 
NA 
 
100% 
 
100% 
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3.4 DISCUSSION 
As detailed before, DNA amplification by LAMP combined with lateral flow detection serves as 
an extremely sensitive and specific DNA detection strategy which is well suited for the clinical 
setting. The ability to carry out the reaction for shorter intervals of time to place an upper 
threshold limit on the detection could aid in replacing the cumbersome cell culture techniques, or 
in the least restrict them to only those samples which have been screened by LAMP-Lateral flow 
detection. The use of colloidal gold as reporter particles in lateral flow assays is at best 
qualitative, but when used in conjunction with a sensitive and specific LAMP assay provides a 
reliable detection scheme which is quantitative. Detection on lateral flow strips is rapid (~5 
minutes) and the results can be viewed visually without the need for any instrumentation. 
Moreover, lateral flow strips can be mass produced at a very low cost and can be stored in 
ambient conditions without too much loss in sensitivity.   
 Fortuitously the Bst DNA polymerase is not inhibited by the urea present in urine when 
compared to Taq DNA polymerase, enabling direct patient urine containing E. coli and K. 
pneumoniae cells to be used as target for LAMP amplification. Urine samples with a 
concentration of greater than 100,000 CFUs/mL of urine, determined by bacterial culture 
methods are easily picked up by LAMP, whereas for samples with a concentration less than this 
threshold value are not amplified when performed without DNA extraction. This reduces sample 
handling to a minimum and thus could pave the way for integrated point-of-care devices where 
the reaction and detection takes place in a closed system to give a qualitative ‘yes’ or ‘no’ 
answer in less than an hour. We report here a cost effective and rapid diagnosis method to detect 
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E. coli malB, E. coli STX-1 and K. pneumoniae in human urine. Multiplexing the amplification 
by LAMP for the detection of two organisms has also been achieved which not only saves cost 
of reagents, but also time for detection is reduced. The total cost of the reagents for the LAMP 
reaction and its subsequent detection on lateral flow strips when mass produced does not exceed 
a dollar. The isothermal requirements of LAMP, high specificity, minimal sample preprocessing 
coupled with the sensitivity of the lateral flow detection makes this detection scheme very 
promising for point-of-care diagnostic applications in developing countries.  
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4.0  SUMMARY AND FUTURE OUTLOOK 
DNA-based biosensors have tremendous potential to be used in point-of-care diagnostics 
primarily due to their unparalled specificity and the ease of fabricating sensor substrates with 
DNA molecules. DNA molecules can be immobilized onto substrates such as glass, gold, silicon, 
carbon, etc. by using chemistry which is well known. The use of thiolated DNA which self-
assemble or through functional alkanethiol monolayers on gold, biotinylated DNA strands on 
avidin coated surfaces, carbodiimde chemistry for carbon surfaces, physical adsorption, etc. are 
some of the more commonly used immobilization techniques. Unlike proteins, DNA molecules 
are more robust and the sensor surface can be regenerated easily by chemically or thermally 
induced dehybridization.   
Typically, DNA biosensors are based on the recognition of the hybridization of a 
complementary strand or  the detection of an amplified DNA product. The hybridization event 
must produce a noticeable change either through an appropriate indicator or by monitoring other 
changes brought about by the duplex formation. The conditions for solution hybridization such 
as temperature, ionic strength, presence of accelerators, etc. have to be optimized. DNA 
hybridization events can be detected using optical, electrochemical, piezoelectric or colorimetric 
methods as detailed in Chapter 1 (Pg 4).  Label free methods are more sought after as it reduces 
the complexity of adding the label to the target strand which needs to be detected. DNA 
microarrays which have revolutionized the genetic analysis can perform rapid multiplex DNA 
hybridization assays with high precision which is of immense value in the detection of genetic 
mutations, infectious diseases, gene expression and forensics. Single strand DNA is imprinted at 
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a high density on these “chips” which are then scanned by a laser for the detection of 
hybridization events. Hundreds of different sequences can be analyzed at a given time giving 
great flexibility and reducing time. However, all these commercial devices which utilize DNA 
hybridization either require labels or are generally too expensive to be used as point-of-care 
sensors. In this work, we propose an alternative route to the conventional DNA hybridization by 
successfully detecting DNA mutations by examining the viscoelastic properties of ssDNA 
strands and secondly, by using a rapid, isothermal DNA amplification scheme coupled with 
detection of the amplified product on low cost lateral flow strips.    
In the first part of this work, the ssDNA’s ability to form sequence dependent unique 3-D 
conformation in solution is utilized to distinguish between the wild and mutant type DNA. We 
have shown that when the wild type ssDNA strands are immobilized onto a substrate to form a 
ssDNA film, the film’s viscoelastic properties are different from that of the mutant type ssDNA 
film.  The p53 gene was used as a case study and appreciable differences in the p53 wild type 
ssDNA film and p53 R type mutant ssDNA film were observed. The differences between the 
wild type and mutant type ssDNA films can be maximized by including different fragments of 
the gene which contain the mutation and technically, there is no upper limit on the number of 
bases that can be screened. The sensitivity can be further improved by using MEMS/NEMS 
devices operating in the resonant mode, where extremely high frequencies in the GHz range and 
high Q-factors can be obtained. This would greatly increase sensitivity, reduce power 
consumption and importantly make it possible to screen multiple samples in a cost effective 
manner. This low cost, rapid, label free mutation screening technique therefore has great 
promise.       
  In the second part of this work, a simpler, more cost effective route to detect infectious 
organisms for point-of-care diagnostics is proposed.  Timely point-of-care diagnosis for life 
threatening infectious diseases is of paramount importance.  The strategy is to isothermally 
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amplify the DNA with labels and then detecting the labels (haptens) via hapten-antibody binding 
which is faster and more efficient than DNA hybridization. Isothermal amplification by LAMP 
does away with expensive thermal cyclers required for PCR and does not require the use of 
skilled personnel which is ideally suited for point-of-care applications. Also, another distinct 
advantage of LAMP over PCR is that minimal sample preprocessing is required. We have shown 
that direct patient urine samples can be readily used without inhibiting the Bst strand displacing 
enzyme which greatly simplifies the detection scheme. With careful design of labeled DNA 
primers multiplexing detection of two organisms is possible and the sensitivity and specificity of 
the detection of the amplified product on lateral flow strips is comparable to PCR and bacterial 
culture methods. Detection on lateral flow strips is attractive as the strips are cheap to 
manufacture, do not require instrumentation to read it  and amount of DNA present after LAMP 
amplification (~106 copies) is sufficient to ensure a high sensitive and specific detection. In 
future, we envision an integrated and self-contained point-of-care device where after the addition 
of the patient sample into the device, the results are viewed on the lateral flow strip and disposed 
off. The LAMP reaction mixture with the reagents and the enzyme is stable at room temperature 
for 20 days and does not require refrigeration. Integrating a chemical heater which maintains 
around 63 – 65 oC with such a device would require no electricity at all to carry out the detection. 
Therefore, considering all the above factors, the LAMP-lateral flow detection scheme thus has 
immense potential to be deployed as a reliable point-of-care diagnostic tool.  
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